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Introduction 
Optical Tissue Clearing (OTC) refers to a wide set of techniques aiming to make large and 
fixed biological tissues optically transparent. The meaning of “large” is related to thick 
sections of tissue, organoids, up to whole organs or organisms (for example, entire mouse or 
rat)
1
. The increasing need of a deeper understanding of morphogenetic and developmental 
processes, in organs and whole organisms, has been leading biologists to push the research for 
establishing methodologies related to volumetric imaging
2
. In this background, many 
researches and testing have been done, for very long time, only on brain, in order to 
reconstruct the neuronal connections and understand the mechanisms of development
3
. 
Moreover, the three dimensional (3D) imaging has been more and more often required also in 
medical and diagnostic fields, to overcome the limitations of the two dimensional (2D) 
structural analysis, performed on thin sections (in the range of a few µm) of biological 
material. A small portion, in fact, could provide only little structural information and, 
additionally, the spatial resolution is a very limiting factor (Spatial resolution: number of 
pixels used for image reconstruction. Usually, a higher spatial resolution image corresponds 
to a greater number of pixels)
2, 4
. In order to obtain 3D information, different approaches have 
been described, such as serial sectioning of samples, followed by volumetric reconstruction
5, 6
 
or the “blockface” approach which involves the imaging of the surface of a block of tissue, 
followed by a sequential shaving of the surface itself
7, 8
. In reality, these options are highly 
labor-intensive and the 3D reconstruction is extremely cumbersome and prone to error. The 
third alternative is to image the volume without tissue slicing, accelerating, in this way, all the 
process and preventing also all the inaccuracies resulting from the sectioning. In theory, this 
could be possible by using confocal, light sheet or multiphoton microscopies. However, the 
more focus goes in depth, the more the quality of the imaging deteriorates incredibly
1
. This is 
mainly due to the lack of transparency of biological samples that is related to many factors. 
The first is the tissue composition and the phenomenon of light scattering. This occurs 
whenever light, after being absorbed by a medium, does not travel in straight lines, as 
theoretically it should do, but rather it is deviated and reflected by the components of the 
medium
2
. Tissues are, in fact, mixtures of different biomolecules, differing to each other for 
many properties and among them there is the refractive index (RI), defined as how much slow 
the light propagates through a certain medium, compared to the vacuum
1
. All the 
biomolecules are characterized by specific RI values
4
: proteins RI~1.43; lipids RI~1.44; water 
RI~1.33, where the overall tissue RI is generally set equal to 1.4-1.5
9, 10
. Moreover, many 
Introduction   - 2 - 
 
pigments confer an overall tissue colouration, as haemoglobin in the blood circulation, 
myoglobin in the skeletal muscle and melanin, which is the primary pigment in hair and skin
2
. 
Due to their chemical structure, this set of molecules is considered as the main responsible of 
visible light absorption in tissue
2
. Another additional trouble regards intrinsic fluorescent 
molecules, involved in arising tissue autofluorescence up and, in the same time, masking the 
fluorescent signal from external labelling. This is the case with NaDPH, collagen, flavins or 
molecules introduced by the formation of Schiff’s bases, caused by fixation with aldehydes2. 
Collectively, all of these components create a lack of homogeneity in tissue, resulting in a 
milky and opaque appearance of the tissue itself
2
. Moreover, the consequent RI mismatch, 
occurring within the tissue, does not allow light pass through the sample and this negatively 
influences the 3D imaging. One example is the spherical aberration, which is a type of image 
degradation, resolving in sharp and unclear images. This happens whenever the matching of 
RIs between sample, mounting solution and objective lens fails
2
. Considering this context, 
OTC, combined to 3D imaging is the optimal solution, providing many benefits to the modern 
biology. Of course, OTCs could not completely remove the light scattering phenomenon, but 
they can, anyway, minimize that. In fact, the general strategy of OTCs is to homogenize the 
RI of a sample, by removing or replacing the components providing the highest rate of light 
scattering from the tissue, in order to make that optically transparent and give, in this way, a 
better transition of light and, consequently, a final volumetric imaging
1
. Due to their high RI 
and their tendency to create aggregates (principal cause of the tissue milky appearance), lipids 
from cells membrane bilayers are defined as the major source of light scattering and, 
therefore, the main component removed or solvated by OTCs
9
. However, prior to any OTC 
method, perfusion to remove blood (and, therefore, haemoglobin) is often required. Whenever 
this could not be an option, other techniques may be used, as, for instance, hydrogen peroxide 
to de-colour haemoglobin
2
. 
1.1 Different OTCs techniques for large samples 
The pioneer of OTC is considered to be Walter Spalteholz, who, in 1914, had developed a 
mixture of benzyl alcohol and methyl salicylate to clear large samples
11
. 
Nowadays, OTCs are grouped into three different categories, based on their mode of action
1, 2, 
4
: 1) simple RI matching; 2) delipidation and dehydration/hyperhydration followed by RI 
matching; 3) tissue-gel hybridization followed by delipidation and RI matching. 
Figure 1.1 represents a schematic overview of all the OTCs described until 2016. 
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Figure 1.1: Schematic overview of all the OTC techniques updates until 2016. Image taken from
12
. 
 
SIMPLE IMMERSION AND RI MATCHING 
The specimens to be cleared are immersed in high RI solutions, which diffuse passively into 
them, without delipidation
2
. Many clearing solutions have been described and these act 
mainly by replacing water, allowing the clearing as well as the RI matching 
2, 4
. Moreover, the 
majority of them are characterized by a quite high RI, in a range between 1.44-1.49
4
. 
Examples are sucrose, fructose (SeeDB technique), glycerol and formamide
7, 13-16
. These 
solutions are easy to implement, economic and the process is totally reversible
2, 4
. On the 
other hand, the clearing efficacy is not so high and this clearing is obtained after a long time 
of incubation. In addition, due to their high viscosity, there is the risk of their precipitation at 
room temperature (RT) and incorporation of air bubbles
2
. Another drawback regards how 
these retain fluorescent molecules: for instance, since the formamide destroys the 
fluorophores, it may easily quench the signal from the inherent fluorescent proteins (FPs)
4
. 
Therefore, in order to overcome these limitations and to lower the viscosity of the previous 
solutions, new solutions have been created, as FocusClear
TM
, Refractive Index Matching 
Solution (RIMS) or FRUIT (a mixture of urea and fructose); in particular, the latter as 
replacement of the first SeeDB solution, to overcome its limitations
17-20
. 
DELIPIDATION AND DEHYDRATION/HYPERHYDRATION FOLLOWED BY RI 
MATCHING 
These methods are based either on high RI (~1.56) organic solvent or on aqueous solutions: 
these latters work to lower the overall RI of the tissue, to ~1.381, 4. In both cases, the optical 
transparency and the RI matching are achieved. 
Organic solvents work by removing and/or solvating lipids. In terms of speed and efficacy of 
clearing, these techniques are better than the aqueous solutions
4
. On the other hand, the tissue 
Introduction   - 4 - 
 
shrinkage caused by the dehydration prior to the clearing (for example by using increasing 
series of alcohol, as methanol or ethanol) might provoke an important shrinkage of the tissue 
and, consequently, decrease quality of the final imaging, despite the advantage of imaging a 
large volume more easily
2
. Additionally, in many cases, a little retention of the fluorescent 
signal has been observed: for instance, after performing 3DISCO, which uses a dibenzyl ether 
(DBE) and tetrahydrofuran (THF), a survival of the green fluorescent protein (GFP) of only 
1,2 days has been noticed
21
. Moreover, the toxicity of the used substances is another 
disadvantage. On the other hand, aqueous solution also remove lipids, but with less toxicity 
and quenching issues. Although they might damage the tissue by hyperhydration, the main 
benefits of these substances are the ease of implementation and the reduced harmfulness
1, 2, 4
. 
Some examples are given by Triton X-100 (non-ionic detergent), urea (denaturant), which are 
used, for example, in CUBIC (Clear, Unobstructed Brain/Body Imaging Cocktails and 
Computational analysis) or ScaleA2 (glycerol combined to urea and Triton)
22, 23
. 
TISSUE-GEL HYBRIDIZATION FOLLOWED BY DELIPIDATION AND RI 
MATCHING 
To protect the biomolecules that could be lost with the use of stringent concentrations of 
organic solvents or detergents, some other techniques have been described. These include the 
use of tissue embedding in tissue gel, followed by delipidation and, then, by incubation in a 
RI matching solution. This is the case with CLARITY (Clear Lipid-exchange Acrylamide-
hybridized Rigid imaging in situ hybridization-compatible Tissue Hydrogel)
24
: here, tissues 
are embedded in a mixture of acrylamide and bis-acrylamide, delipidation is performed by 
sodium dodecyl sulphate (SDS) and RI matching in RIMS contributes to clear the whole 
organ. The delipidation could be achieved either by passive incubation in SDS (for some 
weeks
25
) or by electrophoresis
24
. Thanks to the primary embedding, the protein structures are 
well preserved, as well as the fluorescence from intrinsic and extrinsic molecules. 
 
In summary, the choice of the most correct OTC methodology is really important to prevent a 
premature FPs quenching
26
. In fact, solvent based clearing, as BABB (Benzyl Alcohol/ 
Benzyl Benzoate), iDISCO or 3DISCO (DISCO: dimensional imaging of solvent-cleared 
organs) can easily quench the fluorescence, differently from aqueous clearing solutions, as 
many FPs need a hydrophilic environment to fluoresce
26
. This is the reason why, in order to 
maintain the fluorescent signal (for example from immunofluorescent labels) for a longer 
time, for some organic clearing solution a pre-treatment is often required
26
, whereas the 
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fluorescence survival has been clearly demonstrated in aqueous based techniques, as 
CLARITY, PACT (Passive Clarity technique); SeeDB, immunofluorescent labeling
2, 4, 26
. 
1.2 Microscopy 
The detection of fluorescent signals has always been a great tool for tracking proteins in 
living cells. Although many and different microscopies have been used for the 2D 
visualization, with the advent and the increasing request of volumetric imaging and OTCs, 
fluorescence microscopy has been growing more and more in importance
26, 27
. 
Basically, a fluorescent microscope is strictly related to the mode of action of fluorophores 
(Fluorophore: molecule able to re-emit light after absorbing it. Usually, fluorophores contain 
aromatic rings and groups and are characterized by many π bonds28). These are molecules that 
absorb a specific wavelength and, because of that, the electrons are promoted to a higher 
electron energy state. After a range of time between 1 and 100 ns, these electrons return to 
their stationary state and emit a longer wavelength known as fluorescence
27
. So, a simple 
fluorescent microscope is characterized by: 1) a light source that allows the molecules to 
fluoresce (most common: mercury lamp; more advanced: lasers); 2) excitation filter, selecting 
the excitation wavelength from the light source; 3) dichroic mirror, which separates the 
excitation and emission light; 4) emission filter, that directs light into the 5) detector, which 
diffuses the light to the sample
27, 29, 30
. Many types of fluorescent microscopes exist. They are 
classified on the bases of how the light hits the sample
27
. One of the most common is the 
wide-field microscope (WFM), where the excitation light hits the whole sample and the 
fluorescence could be visible through the oculars (Fig.1.2 A). Moreover, it would also be 
possible to post-process the final image by deconvoluting it, bringing further ameliorations
27
. 
Indeed, to deal with the 3D imaging, advanced fluorescent microscopes have been developed, 
as Confocal, Multiphoton and Light Sheet: together these are better known as scanning 
illumination microscopes
27
 (Fig.1.2 B, C, D). Confocal Microscopy (CM) is a non-invasive 
method of optical imaging, which had been developed to face two relevant issues: 1) 
prevention of out-of-focus and 2) imaging in 3D
27, 29, 31
. CM uses a pinhole in order to block 
the out-of-focus emission light, whereas the in-focus one can pass to the detector (in 
particular photomultiplier tube- PMT) and, thus, illuminates the sample. Any single plane of 
the specimen is scanned back and forth in 2D. Therefore, the final image is assembled as a set 
of pixels for each single plane and, then, as a sum of all the planes scanned
27, 29
. This process 
is known as point-source scanning, which involves the oscillation of a horizontal and a 
vertical mirrors, generating, respectively, x,y scan: the vertical mirror (y) moves much slower 
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than the horizontal one (x). On the other hand, the speed of the latter is extremely reduced 
because of its inertia. Totally, the movement of both mirrors contributes to the slowness of 
imaging, one of the worst drawbacks of this microscopy
29
. Other relevant troubleshooting of 
CM regards the resolution and the high risk of photobleaching. In his work, Hell 
demonstrated that CM fails in distinguishing objects that are more closely than 500-800nm
32
. 
This is mainly due to the focal spot of a lens, which is 3-4 times longer than its with
32
 and as 
the excitation light is not axially confined. This results in a longer exposure of the sample to 
the excitation light, which potentially could lead to a very fast photobleaching
33
. Despite of 
that, CM has been becoming a very useful tool not only in the research field, but also in the 
routine pathology. In their work of 2014, Ragazzi and co-workers demonstrated that it was 
possible to use CM both on normal and pathologic tissue (breast cancer, pathologic lymph 
nodes and papillary carcinoma – the most frequent thyroid malignancy), obtaining high 
resolution with haematoxylin-eosin (H&E) staining
31
. 
On the other hand, the new frontier of microscopy is represented by the Light Sheet 
Microscopy (LSM), especially for the improvements in the speed of imaging and the reduced 
photobleaching
33-35
. There are many types of LSMs, although the concept behind is always to 
illuminate the sample from the side, in a well-defined volume, located around the focal plane 
of the detection optics
33
. This microscopy has been bringing many benefits: first of all this is 
much faster compared to other fluorescent microscopes and offers higher resolution (up to 
subcellular level) on thicker tissues; furthermore, the risk of photodamage and bleaching is 
dramatically reduced
33, 35
. In general, in LSM, the excitation and emission lights are split in 
two different paths, which are orthogonal to each other
33
. 
Among the different types of LSM, in 2008, Keller and co-workers developed the digital 
scanning laser light sheet fluorescence microscopy (DLSM), in order to image entire embryos 
of zebrafish
34
. The logic behind is to have a plane of light, beginning from a side, hitting the 
whole sample
34. One of the tools used to achieve that is the “mirror cup”, surrounding the 
detection objective. This is formed by two mirrors, 45° orientated. The laser hits one of the 
two mirrors; the light is then reflected to the other one and in this way a real light sheet is 
generated, which illuminates each line of the specimen with the same intensity
34
. This is ideal 
for the imaging of large specimens. Given the high speed of imaging, the low risk of 
bleaching and the signal-to-noise ratio, equal to 1000:1
34
, DLSM is a real good candidate for 
the future of the 3D imaging. 
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Figure 1.2: Schematic representation of the light pathway in A) WFM; B) CM, C) Multiphoton Microscopy and 
D) LSM. In all diagrams, points A and B are situated in the focal plane of the lens while point C is outside the 
focal plane. Among them, only LSM works to create an excitation light plane, coincident with the focal plane of 
an imaging objective. Image taken from
36
 
 
1.3 Brief description of organs used in this PhD project 
Both wild type (WT) and pathologic organs were analysed during the PhD project. Discussing 
in detail about the anatomy of the studied organs would be beyond the scope of this thesis; for 
this reason, in order to better identify the different structures further described, only a brief 
anatomic and histologic overview both of WT and pathologic samples will be given. 
1.3.1 WT organs 
KIDNEY 
Kidneys are involved in fluid balance, osmolarity and pH regulation, as well as blood 
filtration, for solutes reabsorbing and excretion of metabolism end products and drugs
37
. The 
basic structural and functional unit of the vertebrate kidney is the nephron. In human, the 
number of nephrons, for each kidney, is estimated to be between 0.8 and 1.5 million
38
. To 
accomplish all the tasks, the nephron has highly specialised segmentation, whose 
development could differ from species to species
38
. In mammals, the main nephron segments 
are the proximal tubules, loop of Henle and distal tubules. In addition, the nephron is 
characterized by specific elements, as solute transporters and tight junctions, which enable the 
fine-tuning salt and electrolyte levels in the body
38
. The Bowman’s capsule is located before 
the tubules. The nephron starts with the Bowman’s capsule and the capillary tuft together with 
the tubules come into play. This is the kidney filtering unit, described as a bundle of 
capillaries, coming from the branching of the afferent artery
39
. Since these are the only 
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capillaries not surrounded by interstitial tissue, different layers are present in order to 
maintain their structures, as the proximal layer, characterized by fenestrated endothelium (70-
100nm in diameter), the glomerular basement membrane (GBM), and the distal layer, 
composed by the podocytes
39
. 
 
HEART 
From a histologic point of view, the three main cardiac tissues are: pericardium
40
, 
myocardium
41
 and endocardium
41
. The myocardium is characterized by striated and 
multinucleated cells, composing the functional unit of the cardiac contraction, the 
sarcomere
41
. The endocardium is the inner cardiac layer, which defines the chambers of the 
heart. It is involved in different roles, as the control of myocardial contractility, the 
electrophysiological environment of the cardiomyocites.  
Normally, the heart vasculature is classified based on the diameter of the blood vessels, where 
the two coronary arteries (left and right), have the widest diameter
42
. The arteries spread out 
into smaller and smaller blood vessel, which are the capillaries, with the smallest diameter
42
. 
Together, this set of blood vessels supply all the heart
41, 42
. 
 
LUNG 
The most important task of lung is the gas exchange, by delivering oxygen and removing 
carbon dioxide from blood circulation. Surrounded by the external visceral pleura, to 
accomplish this task, its inner part is organized as three-like system of conducting airways 
ventilating the gas exchange area, made by bronchi and bronchioles
43
. The functional unit of 
the lung is called alveolus, which represents the terminal bronchioles and is located in the 
lung parenchyma. From the outside, these are composed by an epithelial layer and 
extracellular matrix, surrounded by a set of blood capillaries. Within the alveoli is a very thin 
air-blood barrier for gas exchanges
43
. In addition, the bronchi follow the pattern of the 
pulmonary arteries, which are surrounded by connective tissue
44
. 
Many and different cell types are found in the lung
44
: 
 Ciliated cells, whose main role is to remove foreign microorganism; 
 Goblet cells, located in the larger bronchi, but not in the bronchioles; 
 Basal cells, which are pluripotential reserve cells, which assure the reconstruction of 
the bronchial mucosa; 
 Alveolar cells type I and II, which are on the wall and on the surface of the alveoli. 
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LIVER  
The liver is the biggest gland of the mammalian organism, with many functions in the 
organism, above all in the metabolism of glucose. It is involved in detoxifying metabolites 
from blood, glycogen storage, synthesizing plasma proteins as well as in the production of 
bile, which is important for digestion. From an anatomic point of view, the liver is divided in 
left and right lobes, where each lobe may be classified as the liver functional unit
45, 46
. 
Concerning its vasculature, it receives up to 25% of total cardiac output, where the hepatic 
artery receives between 25% and 30% of the blood supply, and the portal vein all the rest of 
the blood supply. Both of them converge within the hepatic sinusoids before draining into the 
systemic circulation via the hepatic venous system
46
. In addition, the biliary drainage is made 
by the intrahepatic biliary tree, characterized by several ducts, involved in the formation and 
transport of bile from the liver to the duodenum, by following the portal venous system
46
. 
Each liver lobule is formed by hepatocytes (parenchymal cells, which occupy 80% of the 
entire total volume of the liver and represent the 60% of the total cells), performing the 
majority of liver functions) and non-parenchymal cells which occupy only 6.5% to 
the liver volume)
47
. The non-parenchymal cells include different type of cells, as sinusoidal 
endothelial cells, which cover the fenestrated endothelium; Kupffer cells: macrophages 
allocated in the hepatic sinusoids; hepatic stellate cells (alternatively called Ito cells). The 
cytoplasm of these cells particularly abounds in lipid vesicles rich with vitamin A
47
. 
SPLEEN
48
 
The spleen is classified as a hollow organ, belonging to the immune system. Its main function 
is filtering blood. From the outside, the spleen is surrounded by a capsule of connective tissue, 
which works to supply its bloodstream. The main elements of the spleen are the red and white 
pulps, the capsule of connective tissue and the marginal area. The red pulp is composed by a 
high specialised venous system which gives to that the unique red colour. Arterial blood 
comes into cords of connective tissue, known as Cords of Billroth. These create an open 
blood system without any endothelial coating. Its primary role is to filter microorganism and 
antigens from blood by the mechanism of erytrhophagocytosis, made above all by 
macrophages. This is extremely important both for the turnover of erythrocytes and recycling 
of iron. The structure of the white pulp reminds to a lymph node. This hosts lymphocytes as T 
and B cells; the arteriole is centrally located within pulp. The marginal area comes between 
the two pulps: this is a massive transit area, which allows the migration of haematopoietic 
cells from the bloodstream to the lymphoid regions and back. The maintaining of its integrity 
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is assured by resident cells. From a microscopic point of view, the amount of blood vessels 
defines the brightness of the components. Therefore, due to the less quantity of blood vessels 
and the greater concentration of lymphatic tissue, the white pulp results darker than the red 
one. 
1.3.2 Pathologic organs 
KIDNEY INJURY CAUSED BY CISPLATIN TREATMENT  
Cisplatin is a powerful chemotherapy drug, it may provide many side effects; one of the most 
relevant is nephrotoxicity, leading to acute and chronic kidney injury (AKI; CKI)
49
. In 
particular, the consequences of cisplatin-induced AKI have been proven in tubular injury (cell 
damage and dilatation), alteration of the levels of inflammatory cytokine and chemokine (for 
example TNFα), increase of macrophages levels (M1 and M2 – respectively pro and 
antyinflammatory macrophages, which are the key mediators of AKI), profibrotic factors (as 
TGFβ and CTGf), as well as Bowman’s capsules and capillary changes49 . 
AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY (ADPCK) 
One of the most common genetic causes of renal failure is Polycystic Kidney Disease 
(PKD)
50
. From a histological point of view, renal cysts are found between cortex and medulla, 
arising from every segment of the nephron (this is, actually, the distinctive feature only of the 
dominant form and not of the recessive one). Depending on the progression of the disease, 
they may appear in different colours: from clear to yellow to brown (which is a clear sign of 
haemorrhages)
51
. In addition, the cysts may contain different ions (Na
+
, Cl
-
, K
+
), growth 
factors (as, for example, epithelial growth factor), proteases and erythropoietin
51
. Moreover, 
in the final stage of the disease, glomerular atrophy and interstitial fibrosis may appear, but 
with no inflammatory infiltrates associated to
51
. 
Aims of the study   - 11 - 
 
2. Aims of the study 
The goal of this PhD project was to optimize and develop new approaches for visualizing and 
3D-imaging tissues and whole organs. Essentially, these approaches were based on 
optimizing OTC methodologies in combination to the use of CM and LSM. 
The core of this research was about the Ethyl Cinnamate-based OTC: starting from a recently 
published protocol
52
, we worked in order to speed up and automate all the procedures, making 
it suitable for further studies. Initially we started with the clearing only of mouse kidneys and, 
then, the procedure was extended to other tissues (normal and pathological tissues) not 
previously analysed yet. 
Additionally, we enhanced this methodology, with its application for different scopes, as “re-
vitalization” of old paraffin samples and 3D immunohistochemistry for visualizing finer and 
inner structures.  
Our clearing protocol was also tested, for some preliminary studies, on human tissue, with 
promising results. In parallel, we also tried to figure out the best conditions for the use of both 
CM and LSM, in order to acquire 2D and 3D images for very large samples. 
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3. Animals, material and methods 
3.1 Animals 
All animal experiments were conducted in accordance with the German Animal Protection 
Law and approved by the local authority (Regierungspräsidium Nordbaden, Karlsruhe 
Germany in agreement with EU guideline 2010/63/EU), under anaesthesia. 
Unless stated otherwise, 16 weeks old female C57BL/6 wild type mice were used. 
The anaesthesia was induced by intra-peritoneal injection of Ketamine and Xylazine (16 
mg/kg BW xylazin and 120 mg/kg BW ketamine). 
3.2 General workflow of Optical Tissue Clearing 
OTC general workflow consists of three major steps: 
- Pre-processing, which is the animal perfusion; 
- Processing, the OTC itself; 
- Post-processing, i.e. samples analysis through the microscope. 
 
In Figure 3.1 all the equipment used during the PhD project is shown, as a general overview 
of the protocol. In order to reach all the organs of the body of the animal, a retrograde 
perfusion protocol was set up, using a pressure (200mbar) and volume controlled system
53
. 
The equipment consists in a compressor (Jun-Air compressor, Rio Grande, 117301). To keep 
the pressure constant and under control, tubes of 0.58 mm of diameter were used. The 
compressor is connected to two bottles, containing a mixture of NaCl/heparine (0.9% NaCl, 
pH=7.4; heparin 5 IU/mL) and 4% paraformaldehyde (PFA) respectively. In addition, the 
device is connected to a syringe pump (Chemyx, Fusion 100 infusion pump) for dye injection. 
This pump controls the amount of the dye, so that it could be administered at a constant rate, 
which was set to 1ml/min. This tubing system is, furthermore, connected to a three-way valve, 
linked to a G25 butterfly needle. Under anesthesia, the abdominal skin and muscle of the 
animal is cut and then, the needle is inserted into the bifurcation of the aorta and the vena cava 
is opened. The first step is to remove all the blood from the animal body by flushing with 
NaCl/heparine (~40ml) in 6 minutes. The presence of the heparin avoids the blood 
coagulation. Then the dye is injected, at a rate of 1ml/min. In order to eliminate the excess of 
the unlinked dye, the animal body is flushed a second time with NaCl/heparine for 1minute. 
Optionally, a second dye is injected, followed by another minute of saline. Lastly, all the 
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organs are fixed by using 4%PFA for 6 minutes (~40ml). For this project kidneys, heart, liver, 
lungs, spleen were taken out and stored in 4%PFA at 4°C, until further processing. 
 
 
 
Figure 3.1: General overview of the equipment, for the OTC protocol, used during the whole PhD project. On 
the left side the compressor linked to the bottles for the perfusion; in the middle the instrument for clearing and 
on the right the confocal microscopy i.e. one of the two microscopes used for 3D imaging. Image taken from
53
. 
 
Ethyl Cinnamate Based OPTICAL TISSUE CLEARING 
A new clearing procedure has been recently described by Klingberg et al. in 2017
52
, based on 
the use of ethyl-3-phenylprop-2-enoate (Ethyl Cinnamate – ECi – Fig.3.2). Chemically, ECi is 
the ester of cinnamic acid and ethanol and this is the principal component of cinnamon 
essential oil. It is an organic solvent and a lipophilic reagent. It is considered a nontoxic 
chemical and it is already used as food and cosmetic additive, according to the approval from 
Food and Drug Administration (FDA)
54
. The ECi-based clearing procedure, provided by 
Klingberg’s group, is described by two major steps: a dehydration step, by using different 
increasing ethanol concentrations, at 4°C, for lipid extraction and the following clearing, 
made by the ECi at RT. The total procedure is conducted in a gentle shaking movement and 
lasts between 16 and 20 hours
52
. 
One of the aims of this PhD project was to optimize this protocol, in order to make it faster 
and easier to perform. One of the first steps was to automate it, performing the whole 
protocols in a tissue processor (TP1020, Leica Biosystem, Nußloch, Germany), which works 
with vacuum and RT. All the equipment, subsequently mentioned, is related to the tissue 
processor and was provided directly with it. The specimen are placed into metal boxes and, 
then, into a basket, which moves, automatically, into different containers, where the first four 
are filled with ethanol in increasing concentrations (50%,80%,100%,100%) pH 9.0, for the 
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dehydration steps. Each passage lasts 45 minutes. Lastly, the clearing step by ECi (Sigma-
Aldrich, Germany, STBH5252, R.I. 1.558 at 25°C) occurs, for 2 hours, although the samples 
might stay longer in the solution, i.e. overnight. After completing the procedure, the specimen 
are collected and stored in ECi, at RT, until imaging. At this point it could also be possible to 
allow them to stay under gentle shaking, in order to let the ECi penetrate more deeply. 
 
 
 
 
 
 
MICROSCOPY 
The post-processing involves the microscopy: both Confocal (Leica TCS SP8, provided by 
Leica Biosystem, Mannheim, Germany) and LightSheet (Leica TCS SP8 DLS, provided 
Leica Biosystem, Mannheim, Germany) microscopes were used for tissue analysis. In the 
following, a brief description regarding the microscope settings will be given. 
The following table (Tab. 3.1) illustrates the working distances of the different objectives 
used as well as all the mounting media and their own RIs. 
 
 
 
 
Figure 3.2: ECi Chemical structure. 
www.pubchem.ncbi.nlm.nih.gov 
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MICROSCOPE 
 
OBJECTIVE WORKING 
DISTANCE (mm) 
MOUNTING 
MEDIUM  
Confocal  63x ( HC PL APO 
63x/1.40 Oil CS2 – 
Leica 
Microsystems, 
Germany) 
0.14 Immersion Oil Type 
F (Leica 
microsystems TM); 
Glycerol 
(OmniPur® Glycerol, 
Merck, Darmstadt, 
Germany) 
R.I: 1.518 at 23°C; 
R.I:1.475 at 20°C
55
  
Confocal 20x (HC PL 
20x/075 IMM 
CORR CS2 – Leica 
Microsystems, 
Germany) 
0.68 Immersion Oil Type 
F (Leica 
microsystems TM); 
Glycerol 
(OmniPur® Glycerol, 
Merck, Darmstadt, 
Germany) 
R.I: 1.518 at 23°C; 
R.I:1.475 at 20°C
55
 
Confocal 10x (HCX APO L 
10x/0.30 W U-V-I 
– Leica 
Microsystems, 
Germany) 
3.60 Distilled Water 
R.I: 1.33
56
 
LightSheet 5x(HC PL 
FLUOTAR 5x/0.15 
IMM DLS, 
Leica 
Microsystems, 
Germany) 
1.5 Glycerol 
(OmniPur® Glycerol, 
Merck, Darmstadt, 
Germany); ECi  
R.I: 1.475  at 20°C 
(
55
); 1.558 at 
25°C
57
 
Table 3.1: Description of the different objective used and their features (working distances, 
immersion media and refractive indexes). 
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Moreover, another important issue is how to properly mount the specimen, in order to avoid 
troubles, regarding the z-dimension. Depending on the microscope used, two ways of sample 
fixation were settled: 
Confocal Microscope: Fixation by needle. On the border of a 60mm tissue culture dish 
(Orange Scientific, Belgium) was attached some adhesive paste (HAMA), in order to fix a 
G271/2 needle to anchor the specimen. After positioning the specimen, the dish was filled with 
immersion oil (R.I.:1.518 at 23°C), until the specimen was completely covered. This approach 
may alternatively use the pasting of the tissue on the centre of the dish, by using a big drop of 
super glue (UHU).  
LightSheet Microscope: Fixation with parafilm. The objective of this type of microscope is 
surrounded by a mirror cap, where the mirrors are orientated at 45° and, due to that, the 
specimen should fit in the spaces created by this orientation. Another aspect regards the 
height of the sample which should not exceed 0.5mm in order not to touch the lens of the 
objective. Keeping in consideration these two pre-requisites, the most suitable method to 
anchor the samples based on sticking a piece of parafilm of 0.1mm in thickness in the centre 
of a glass bottom cell culture dish (35mm high, 60µm in diameter, IBIDI, Martinsried, 
Munich, Germany). On that, a piece of the specimen, maximum 0.4mm in width and 0.5mm 
in height was used to be pasted, by using the superglue. Finally, the dish was completely 
filled by either ECi or 88% glycerol (R.I.:1.475 at 20°C
55
). The parafilm helps in making the 
specimen higher, in order to allow it to be easier reachable by the mirrors and to avoid their 
direct contact with the bottom of the dish. In fact, this could be a risk in breaking the dish. 
IMAGING SETTINGS 
Data from both microscopes were acquired by Las X software (Leica Biosystem, Nußloch, 
Germany).  
Confocal Microscope: in order to balance the acquisition time and the quality of the pictures, 
three parameters were kept constant: the format (resolution) 1024*1024; the speed 600Hz and 
the scan direction X set to Bidirectional X.  
LightSheet Microscope: due to the working distance of the objective of this microscope, it is 
possible to reach a maximum depth of 1.5mm. The settings were settled, keeping in 
consideration an additional issue: the amount of generated data, which depends on different 
criteria: a) the resolution (in terms of binning); b) the possibility to work either with the left or 
right mirror singularly or with both of them; c) the size and the depth of the region of interest 
to be scanned. Due to that, the usual resolution was set to 2*2 binning at 600 Hz of speed. 
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Storage data: All the data acquired from Confocal and LightSheet microscopy were stored in 
the Scientific Data Storage (SDS), provided by the Computing Center of University of 
Heidelberg (Germany). 
3.3. Staining 
In the following sections, a list of all the dyes used is reported. Except for the antibody 
staining, performed by incubation, all dyes were injected during the perfusion at a constant 
rate of 1ml/min.  
3.3.1 MHI148-PEI  
The cationic MHI148-PEI (since now on named Cy7-PEI – Fig.3.3) was used to stain anionic 
structures
53
. This is a near-infrared (NIR) dye (Fig.3.4), coming from the combination of 
heptamethine cyanine dye (MHI148) and branched polyethylenimine (PEI), synthetized at the 
Zentrum für Medizinische Forschung (ZMF), Universitätsmedizin Mannheim (Germany), and 
patented according the code WO/2018/100089. This dye had been designed in order to 
visualize in 3D vasculature and glomeruli
53
. In order to design this dye, different biological 
components have been taken in consideration: 
- The negative charge of the glycosaminoglycans (GAGs), main constituents of the 
blood vessels endothelium; 
- The structure of the glomerular capillary wall, made by a fenestrated endothelium, is 
70-90nm in size, a basement membrane of 2-8nm and a fenestrated epithelium, 
surrounded by podocytes, whose extension is 4-11nm in length; 
- The cut-off of the renal basal membrane is supposed to be 50kDa. That suggests that 
under normal conditions molecules bigger than this weight cannot overcome the 
membrane.  
The main features of the Cy7-PEI are:  
- A very strong positive charge, due to the presence of the amino groups on the PEI. So, 
the dye works exclusively for strong electrostatic interactions, binding all the negative 
charged elements; 
- The absorption and emission spectra. These have been measured in 1x PBS, 
respectively 654 and 762nm; (Fig.3.4). That ensures a higher penetration depth, 
reducing the impact of autofluorescence; 
- The molecular weight of the entire molecule (50-100kDa), preventing the passage of 
the dye into the renal tubules and allowing it to stain the glomeruli as well as the blood 
vessels. 
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A variant of Cy7-PEI is the Cy7PEI-opt (optimized), where the only difference is related to 
the bigger molecular weight (in a range between 50 and 150KDa).  
The PEI component works by electrostatic interactions to recognize and bind the negatively 
charged GAGs; in the meantime, the Cy7 component provides the fluorescent staining, which 
will be detected by CM and/or LSM. The dye is in a powder form, whose stock concentration 
was set to be 3mg/ml, to be solved in 1xPBS, followed by the measurement of its wavelengths 
(absorbance and excitation) at the spectrofluorometer (Tecan Infinite M200, provided by 
Tecan Austria GmbH, Salzburg, Austria). 
During the perfusion, a 10 minutes injection was used (according at the rate of 1ml/min; 
totally, 10 ml). 
 
 
 
Figure 3.3: Molecular structure of MHI148-PEI. The figure summarizes the chemical procedure to obtain the 
MHI148-PEI. Image taken from
53
. 
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Figure 3.4: Fluorescence spectra of MHI148-PEI. The figure shows the absorption (black curve, on the left side) 
and emission (green curve, on the right side) spectra. As pointed out from the graph the maximum absorption is 
at 650nm and the emission at 774nm, listing the dye in the NIR region of the visible spectrum. Image taken 
from
53
. 
 
 
 
3.3.2 Wheat Germ Agglutinin  
Wheat Germ Agglutinin (WGA) is a lectin. Lectins are a big family of ubiquitous proteins, 
carbohydrate-binding. These are known both in animals and in plants. Normally, the lectins 
recognize and bind to polysaccharides of the cells membranes. In plants, they are supposed to 
activate the complement system. WGA is a wheat specific lectin, which protects the wheat 
from insects, yeasts and bacteria by linking itself to N-acetylnerumaninc acid, as components 
of carbohydrates from cells membranes
58
. Due to their ubiquity, it is possible to find lectins 
everywhere: this peculiarity has been exploited to make a way of staining, by adding 
fluorescent molecules, easily microscopically detected.  
In our case, WGA was used as conjugated to AlexaFluor
TM
 488 (W11261, ThermoFischer 
Scientific, Germany). Its absorption and emission peaks are 490 nm and 520 nm respectively 
(Fig.3.5), assigning it in the green region of the visible spectrum. The stock concentration was 
1mg/ml, diluted at 1:1000 in a final volume of 20ml. During the perfusion, it was used as both 
single dye and second dye, like a counterstaining. In both cases, it was injected for 10 min and 
(rate 1ml/min, totally 10ml). 
 
 
 
 
 
Figure 3.5: Fluorescence spectra of Wheat Germ Agglutinin AlexaFluor
TM
 488 conjugate. The figure 
shows the absorption (blue light curve, on the left side) and emission (red light curve, on the right 
side) spectra. As pointed out from the graph the maximum absorption is at 490nm and the emission 
at 520nm, assigning the dye in the green region of the visible spectrum: www.thermofisher.com. 
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3.3.3 Haematoxylin and Eosin (H&E) 
H&E staining is one of the most important and frequently used staining in histology usually 
used on 3-4µm sections of paraffin embedded tissues, previously de-waxed in xylene and 
hydrated in water
59
. This is a differential staining, where haematoxylin is used to stain cellular 
nuclei and eosin to counterstain the cell cytoplasm. Both dyes are fluorescent. In particular, 
haematoxylin binds to basophilic molecules into the cells nuclei (such as DNA and RNA) 
and, in the staining, appears purple/blue in colour. Haematoxylin itself is a colourless 
flavonoid, extracted from the logwood tree Haematoxylon campechianum
59
. When it is 
exposed to air, it is oxidized to haematein (Fig.3.6) and this is the compound which truly 
works for the staining. Chemically speaking, this form is also amphotheric, becoming red at 
acid pH and blue at basic pH. The oxidation occurs by combining the haematoxylin with 
sodium iodate, as oxidant agent, plus potassium sulphate as mordant
59
. Since the beginning of 
the XX century, many mordants have been described such as ammoinium or potassium 
aluminum sulfates, potassium alum, mercuric oxide and ammonium alum, ferric ammonium 
sulphate
59
.  
 
 
Figure 3.6: The chemical process of the oxidation of the haematoxylin in haematein, so that the compound 
which, truly, works in the process of the staining: www. leicabiosystems.com 
 
 
In turn, eosin was discovered in 1874 by Heinrich Caro, who added bromine to fluorescin
60
. 
Eosin, in fact, defines a group of fluorescent molecules binding eosinophilic compounds like 
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proteins with high percentage of arginine or lysine, as amino acids. The most known eosin 
molecules are the Y and B forms (Fig.3.7 A and B), respectively a tetrabromo and dibromo 
derivatives of the fluorescin. As counterstaining, the most used is the Y variant, which makes 
the cytoplasm coloured in pink/reddish.  
 
 
   
Figure 3.7: The two forms of eosin. A): Y form, which is a tetrabromo derivate. B): B form, a dibromo derivate: 
www. sigmaaldrich.com 
 
Taking into account the fluorescence of these dyes, some mouse, rat and human kidney 5µm 
slides, stained with the standard H&E protocols of staining, were imaged with CM. 
For this purpose, two protocols were used: one from the ZMF, Universitätsmedizin 
Mannheim (Tab. 3.2 a) and the second from the Pathology Department of Universitäts 
Klinikum of Mannheim (Tab. 3.2 b). 
 
 
 
 
 
 
 
 
A B 
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ZMF H&E staining protocol 
Protocol performed in the Autostainer XL, 
provided by Leica Biosystem, Mannheim, Germany 
Reagent Time (min) 
Xylol 1 (x4) 
99% Ethanol 1 
96% Ethanol 1 
80% Ethanol 1 
70% Ethanol 1 
dd H2O 1 
Hematoxylin 4 
dd H2O 10 
0.5% aqueous Eosin 2 
96% Ethanol 1 (x2) 
99% Ethanol 1 (x3) 
Xylol 1 (x2) 
Material 
Hematoxylin Hämalaun sauer nach 
Mayer 
Eosin Eosinlösung 0.5% 
wässrig 
Table 3.2 a: Description of the H&E staining 
protocol 1 
 
Pathology Department H&E staining protocol 
Reagent Time (min) 
Xylol 2.30 (x2) 
100% Ethanol 1 
96% Ethanol 1 
80% Ethanol 1 
dd H2O 1 
Hematoxylin 2 (x2) 
Water bath 3 
0.5% aqueous Eosin 1 (x2) 
Water bath 1 
96% Ethanol 1 (x2) 
100% Ethanol 1(x3) 
Material 
Hematoxylin Hämalaun sauer nach 
Mayer 
Eosin Eosinlösung 0.5% 
wässrig 
Table 3.2 b: Description of the H&E staining 
protocol 2 
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Furthermore, some experiments on whole mice and rats were performed, in order to figure out 
the effect of this staining on whole organs. Different combinations of H&E (Dr. K.Hollborne 
& Söhne GmbH & Co Kg, Leipzig, Germany) were injected during the perfusion, by keeping 
the pressure constant and following the usual rate at 1ml/min. The diverse trials are 
summarized in Table 3.3.  
 
TRIAL N. MOUSE N. REAGENT TIME (min) VOLUME (ml) 
1 1 
NaCl pH 7.4 + hep 6 ~40 
Cy7PEI 10 10 
NaCl pH 7.4 + hep 1 ~7 
Haematoxylin 5 5 
NaCl pH 7.4 + hep 1 1 
Eosin 5 5 
NaCl pH 7.4 + hep 1 ~7 
4%PFA 6 ~40 
2 1 
NaCl pH 7.4 + hep 6 ~40 
Haematoxylin 5 5 
NaCl pH 7.4 + hep 1 ~7 
4%PFA 6 ~40 
2 2 
NaCl pH 7.4 + hep 6 ~40 
Eosin 5 5 
NaCl pH 7.4 + hep 1 ~7 
4%PFA 6 ~40 
3 1 
NaCl pH 7.4 + hep 6 ~40 
Haematoxylin 3.5 3.5 
NaCl pH 7.4 + hep 1 ~7 
Eosin 1.5 1.5 
NaCl pH 7.4 + hep 1 ~7 
4%PFA 6 ~40 
3 2 
NaCl pH 7.4 + hep 6 ~40 
Haematoxylin 1.5 1.5 
NaCl pH 7.4 + hep 1 ~7 
Eosin 3.5 3.5 
NaCl pH 7.4 + hep 1 ~7 
4%PFA 6 ~40 
Table 3.3: Sum up regarding the three different trials about the perfusion made by H&E. The pressure has to 
be considered set at 200mbar. 
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3.3.4 3D Immunohystochemistry 
In the following section a list of antibodies used is reported.  
- Polyclonal Goat Anti-Nephrin primary antibody (AF3159), purchased by 
R&DSystems, Germany; 
- Chicken Anti Goat Secondary Antibody AlexaFluo 647 conjugated (A21469), 
purchased by ThermoFisher Scientific, Germany; 
- Normal Unconjugated Chicken Serum, purchased by Jackson ImmunoResearch 
Europe Ltd, UK; 
- SYTOXTM Green Nucleic Acid Stain (S7020), purchased by ThermoFisher, Germany 
Scientific. 
3.4 Validation data: comparison, shrinkage studies and lipid assay 
In order to understand which of the two ECi-based OTCs could result in more shrinkage, 
some studies were conducted. By following the procedure, described by Araujo et al. in 
2014
61
, weight (g), area (in cm
2
) and volume (cm
3
) of the samples before and after the 
clearing procedures were measured. After positioning the samples on a graph paper 
(minimum unit of measurement 1mm), the three dimensions (length, width and thickness, 
referred as r1, r2, r3 respectively) of each sample were measured. The area was calculated by 
multiplying r1*r2, while the volume was calculated by applying the formula for the 
calculation of the volume of the ellipsoid: V=4/3 *π* (r1*r2*r3). Furthermore, also a lipid 
assay was performed before and after the clearing procedures by using the Phospholipids 
Assay Kit (Sigma-Aldrich, Germany, Catalog Number MAK122), in a final ratio buffer/tissue 
of 1ml:100mg. 
3.5 Alternative uses of ECi-based OTC 
3.5.1 De-paraffinization and clearing of paraffin blocks 
Paraffin blocks were treated in a way to ensure, at the same time, both de-paraffinization and 
clearing of the specimens within them. For this purpose, a smaller tissue processor, the Leica 
EM TP (provided by Leica Biosystem, Nußloch, Germany), was used, which allowed to run a 
maximum of 4 samples in one go. The protocol is the following: 
- Initially, the block was placed into an incubator at 60°C for ~20min, to allow the 
paraffin melting, so that it could easier be removed; 
- After carefully removing the melted paraffin, the specimen was placed in the first vial 
of the machine, containing pre-heated (60°C) xylol, for 90min; 
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- Then, automatically, the sample moves to a second xylol vial (60°C; 90min); 
These two stages were introduced to remove all the residues of paraffin. 
- A very strong dehydration was performed in the next three vials, containing 100% 
ethanol (35°C and 90min. for the first two ones; 35°C and 45min, for the last one); 
- Finally the clearing was performed by moving the sample in three different vials 
containing ECi (35°C and 60min x2; 35°C and overnight x1). 
Once completing the process, the specimens were stored in ECi at RT (optionally, on a roller), 
until the imaging. This was performed by using the same settings as previously described, 
both for CM and LSM. 
3.5.2 ECi removal and 3D Immunohistochemistry 
Starting from the protocols published by Dickie et al. in 2006
62
 and Gleave et al. in 2013
63
, a 
new 3D immunohistochemistry (3D-IHC) protocol after ECi-based OTC has been 
established. Before proceeding with the protocol itself, the innovative and essential step was 
to remove ECi, within the organs, and to perform a further second rehydration. In fact, the 
massive use of hydrophilic substances combined with the presence of ECi (hydrophobic) 
could have negatively affected the final results. The protocol has been tested on WT mouse 
kidney. 
After perfusion and fixation in 4% PFA, sections of 1mm of kidney were cut, by using either 
a Vibratome (VT1200/S, provided by Leica Biosystem, Nußloch, Germany) or a rat heart 
matrice (65-2100, provided by AgnTho’s AB, Lidingö, Sweden) before the clearing 
procedure. The ECi removal and the second rehydration consisted in the reverse process of 
the dehydration prior to the clearing, slightly changing the ethanol incubation times (99% 
60min; 99% 45min; 80% 45min 50% 60min). The samples were, then, stored in 1xPBS at RT 
overnight. The next day, in order to better unmask the proteins, antigen retrieval was 
performed by incubating the sample in citrate buffer pH 6.0 at 37°C for 24 hours. Afterwards, 
a quenching step was required to reduce the autofluorescence and the background level from 
the samples. To do that, the samples were incubated in 500mM Glycine (Sigma-Aldrich, 
Germany, GE17-1323-01) for at RT 24 hours, by alternating the use of the roller for 2 hours 
and the sonicator for 15’. Lastly, the sample was incubated at 37°C overnight. The 
permeabilization step was performed, by using Triton X-100 (Sigma-Aldrich, Germany, 
9002-93-1) in 1x PBS at 37°C, totally for 48 hours: 1% for the first 24 hours and 2% for the 
second 24 hours. The blocking in 5% Chicken Serum occurred at 37°C for 48 hours, by 
changing the solution every 24 hours. The primary antibody (Antibody against Nephrin; stock 
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concentration: 0.2mg/ml, diluted 1:100, in a final volume of 5ml) was incubated at 37°C 48 
hours changing the solution every 24 hours, and, then, a washing step in 1x PBS at RT 
occurred. The secondary antibody (Antibody anti Goat AlexaFluo 647 conjugated - stock 
concentration 2 mg/ml, diluted 1:200, in a final volume of 5ml) was incubated at 37°C for 72 
hours changing the solution every 36 hours. Finally, a 24 hours washing in 1x PBS at RT step 
was performed. Furthermore, a nuclear staining was performed, by using Sytox
TM
 Green 
(stock concentration 5mM, diluted 1:20.000, in a final volume of 5ml), in PBS-T incubated at 
37°C overnight. After washing in 1x PBS at RT, the sample was made ready for the imaging. 
The imaging was performed by CM, by using either 20x or 63x in 88% glycerol. The analysis 
was performed after incubating the slice in 88% glycerol for 24-48 hours, at RT, for RIs 
correction.  
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4. Results 
4.1 Perfusion 
In the following table (Tab.4.1) the two different perfusion trials tested, in order to set the 
exact parameters, are listed. To speed the whole procedure up, the second method of perfusion 
was chosen and kept for the overall period of the project. 
 REAGENT TIME 
(min) 
AMOUNT(ml) PRESSURE(mbar) TOTAL 
TIME(min) 
 
1
st
 
TRIAL 
 
NaCl pH 7.4+ 
hep 
6.15 ~41 300  
28.30 
DYE 15 15 300 
NaCl pH 7.4+ 
hep 
1 ~41 300 
4% PFA 6.15 ~41 300 
 
2
nd
 
TRIAL 
 
NaCl pH 7.4+ 
hep 
6 ~40 200  
23 
DYE 10 10 200 
NaCl pH 7.4+ 
hep 
1 ~40 200 
4% PFA 6 ~40 200 
 
 
 
 
4.2 ECi-based Optical Tissue Clearing 
In order to optimize and automate the whole Klingberg’s procedure52, the different 
approaches tested are shown and described in the following tables (Tab.4.2, 4.3, 4.4). All the 
modifications introduced are underlined in red and green. 
FIRST APPROACH 
 
Klingberg et al., 2017 
52
 
REAGENTS CONCENTRATION (%) TIME 
(min) 
TEMPERATURE (°C) 
Ethanol 30 240 4-8  
Ethanol 50 240 4-8  
Ethanol 70 240 4-8  
Ethanol 100 240 4-8  
Ethanol 100 240 4-8  
ECi Absolute 120 RT 
Table 4.1: The table shows the two main trials regarding the perfusion procedure. The second method was kept 
during the whole project. 
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FIRST APPROACH 
(TP1020, Leica Biosystems) 
REAGENTS CONCENTRATION (%) TIME 
(min) 
TEMPERATURE (°C) 
Ethanol 50 240 RT 
Ethanol 80 240 RT 
Ethanol 100 240 RT 
Ethanol 100 240 RT 
ECi Absolute 120 RT 
Table 4.2: The first approach of the optimization is presented. In red the most important modifications made to 
the original protocol. 
In this first approach, the most important changes were: 
- The use of the TP1020, in order to speed the whole process up; 
- The optimized protocol starting from 50% ethanol, instead of 30%. The reduction of 
the number of ethanol steps helped in speeding the procedure up. In addition, to make 
the dehydration stronger, the second ethanol step was increased from 70 to 80%; 
- The cool temperature (4°C) was substituted with RT (~21°C), to improve the diffusion 
coefficient of the different reagents. 
SECOND APPROACH 
 
ECi-based Optical Tissue Clearing 
 (TP1020, Leica Biosystem) 
REAGENTS CONCENTRATION (%) TIME 
(min) 
TEMPERATURE (°C) 
Ethanol 50 60 RT 
Ethanol 80 60 RT 
Ethanol 100 60 RT 
Ethanol 100 60 RT 
ECi Absolute 120 RT 
Table 4.3: The second approach of the optimization is presented. In red the previous modifications which have 
been kept and in green the new ones subsequently made. 
In addition to the previous modifications, related to ethanol concentrations and temperature, 
in this second approach the times for the ethanol steps were further shortened, without 
changing the time for the ECi.  
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THIRD APPROACH 
 
ECi-based Optical Tissue Clearing 
(TP1020, Leica Biosystem) 
REAGENTS CONCENTRATION (%) TIME 
(min) 
TEMPERATURE (°C) 
Ethanol 50 45 RT 
Ethanol 80 45 RT 
Ethanol 100 45 RT 
Ethanol 100 45 RT 
ECi Absolute 120 (o/n) RT 
Table 4.4: The third approach of the optimization is presented. In red the previous modifications which have 
been kept and in green the new ones made on the subsequently. 
 
This is the protocol kept during the whole project. The times for the ethanol steps were further 
reduced to 45 min, without changing the ECi timing, kept to 120 min, although the samples 
may stay longer, for example overnight plus further gentle shaking, to allow ECi penetrate 
better and make the samples clearer. 
4.3 Imaging Settings 
Before listing all the attempts tested, it is needed to underline the difference, in terms of 
immersion media, between CM and LSM. In fact, speaking about CM, all of the attempts 
performed, to mount the samples, were done by using immersion oil, instead of ECi itself, as 
ECi evaporates rapidly. On the other hand, thanks to the much higher speed of data 
acquisition of LSM, it was possible to use ECi, as immersion medium, without facing the 
problem of evaporation. The ways of fixing are listed below: 
a) Glass slide plus coverglass: after cutting a very thin portion from the sample with 
disposable scalpels (Swann-Morton, Sheffield S6 2BJ England), this was placed on a 
glass slide (Ca/env 76*26 mm, Menzel Gläser, Thermo Fisher Scientific Gerhard 
Menzel B.V. & Co., Germany) and covered by a cover glass (24*32 mm, Hirschmann 
Laborgeräte GmbH & Co., Germany). A quite big drop of immersion oil was placed 
on the top of the coverglass; 
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b) Glass slide without coverglass: the same procedure as point a), but without cover 
glass. Immersion oil was placed directly on the specimen; 
c) Agarose embedding: a glass ring was attached on a glass slide (Ca/env 76*26 mm, 
menzel gläser, Thermo Fisher Scientific Gerhard Menzel B.V. & Co., Germany), by 
using silicon. The specimen was oriented in 500µl of melted 1% agarose 
(Invitrogen
TM
 UltraPure
TM
 Low Melting Point Agarose, Thermosfisher Scientific, 
Germany, 16520100) and positioned in the glass ring, by producing 1 or 2 layers. 
Everything was, then, closed by a round cover glass of 22*22mm in size (Thermo 
Fisher Scientific Gerhard Menzel B.V. & Co., Germany), plus immersion oil on top; 
d) Fixation by needle: On the border of a 60mm tissue culture dish (Orange Scientific, 
Belgium) was attached some adhesive paste (HAMA) , in order to fix a G271/2 needle, 
which worked to anchor the specimen. After positioning the specimen the dish was 
filled by either immersion oil or some other hydrophilic mounting media, as PBS, 
distilled water or 88% glycerol, which completely covered the specimen. 
Alternatively, for tissues with a not homogeneous and fragile surface (i.e. liver), which 
could be easily damaged by the insertion of the needle, it was also possible to stich a 
part of that, in the centre of the dish, by using a big drop of super glue (UHU). These 
ways of fixation worked with both immersion oil and hydrophilic mounting media.  
e) Fixation with parafilm (LightSheet Microscope): The most suitable method to 
anchor the samples based on sticking a piece of parafilm of 0.1mm in thickness in the 
centre of a glass bottom Petri dish (35mm high, 60µm in diameter, IBIDI, Martinsried, 
Munich, Germany). On that, a piece of the specimen, maximum 0.4mm in width and 
0.5mm in height was pasted, by using the superglue. Finally, the dish was completely 
filled with ECi. 
 
Method d) for CM and method e) for LSM were used to fix the samples for the 3D imaging. 
Table 4.5 presents a list of advantages and trouble shootings. 
 
 
 
 
 
 
Results   - 31 - 
 
 
 
 
 
 
METHOD ADVANTAGES TROUBLESHOOTING 
a Easy to handle; does not 
require high quantity of 
material 
The architecture of this approach cannot ensure the 
good quality of the scan for different reasons:  
- The small amount of mounting medium is not 
enough for the objective; 
- The sample cannot be well anchored to the glass 
slide; 
- The presence of the coverglass, which cannot be 
well fixed, due to the thickness of the sample. 
As result of all of these factors, the z direction often 
appears twisted and noisy, altering the structural 
data. 
 
b Easy to handle; does not 
require high quantity of 
material 
Despite the removing of the coverglass from the 
specimen, the 3D image is still twisted and noisy. 
Losing many structural data in the 3D image.  
c This approach could solve 
the issue of the movement, 
blocking the specimen in a 
ring of agarose 
Mismatch in RIs between ECi, agarose and 
immersion oil. Very high noise level. 
d No specimen movement; the 
z direction is straight and the 
objective can work with the 
right quantity of immersion 
oil (or, when requested, 
distilled water, PBS or 
glycerol)  
Requires high quantity of material  
e 
 
The sample is well anchored 
on this support and all the 
sizes are very well respected 
Not so easy to handle. 
Table 4.5: List of main advantages and trouble shootings of the different trials regarding the specimen mounting    
on the support. 
Results   - 32 - 
 
4.4 Microscopy Results 
This section will go through the different images, obtained from the aforementioned clearing 
method and the two different microscopes. Unless stated otherwise, the samples were 
harvested from WT mice, strain C57BL/6 and stained with Cy7-PEI in 3mg/ml as 
concentration. 
4.4.1 ECi-based OTC: Results 
The images regarding the first two approaches of the optimization of ECi-based OTC method 
are related mostly to kidney. They are shown in order to go through the different 
improvements and progresses obtained during the diverse phases of the protocol optimization, 
which involves also the one of the perfusion protocol. In fact, these first two trials of ECi-
based OTC were used in combination with the first perfusion protocol. 
On the other hand, the last approach, which was kept overall in the project and used to clear 
not only mouse organs, but also many other types of samples, has always been used with the 
second perfusion protocol.  
FIRST APPROACH 
As indicated by blue arrows in Figure 4.1, the main elements of kidney, as glomeruli, renal 
tubuli and blood vessels are shown in both images: A) in 3D and B) in 2D. Although the 
background noise is still quite high, already from the first trial it is possible to visualise 
“through” in the correct way. 
 
 
 
 
          
 
 
 B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A Figure 4.1: Sections of 
mouse kidney, acquired by 
CM, using a 20x objective in 
immersion oil and the 638 
channel. A) 3D section. As 
indicated by the blue arrows, 
a renal blood vessel and 
glomeruli are visible and 
distinguishable. Scale bar: 
100µm. B) 2D section. Again 
blue arrows are indicating 
structured glomeruli and 
tubules. Scale bar: 75µm 
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SECOND APPROACH 
Figure 4.2 shows a section of mouse kidney, in which the presence of glomeruli as well as 
blood vessels is well underlined, despite still the occurrence of background noise. As 
indicated by the light blue arrow, a renal blood vessel is connected to some glomeruli. 
 
 
B 
Figure 4.2: 3D 
section of mouse 
kidney imaged by 
CM, using a 20x 
objective in 
immersion oil and 
the 638 channel. 
Scale bar: 100µm. 
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THIRD APPROACH 
This is the approach kept throughout the PhD project, as it allowed the imaging of many types 
of samples. In the following section, some examples of different organs cleared and imaged 
will be shown. In order to distinguish which type of microscopy was used (CM or LSM), in 
each caption objective, microscope, mounting medium and channel used will be indicated. 
Mouse Kidney: Confocal Microscopy  
Figure 4.3 is one of the first samples cleared by using the third approach, kept overall in the 
project. Characterized by a very low background noise level, this image reveals in a very clear 
way the glomeruli and renal blood vessels they are linked to. In addition, looking at the 
images in depth coding it is also possible to claim that the glomeruli are present in different 
depth points, confirming, therefore, the functionality of this protocol. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C 
 
 
 
 
 
 
 
 
 
Figure 4.3: 3D Sections of 
mouse kidney, stained with 
Cy7-PEI-opt acquired by 
CM, using a 20x objective 
in immersion oil and the 
638 channel. In A) and B) 
the view, respectively 
without and with depth 
coding, is presented. As 
indicated from the depth 
bar on the right side of the 
image B), the depth 
reached is 250 µm. This 
scale goes from the surface 
of the sample (0-100µm, in 
blue-light blue), middle 
part (100-200µm, in green) 
up to the deepest part of 
the region (200-250µm, in 
yellow-red). Scale bars: 
100µm. 
 
A 
B 
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Figure 4.4 shows results from the WGA staining. Thanks to that, many and different 
structures were imaged in one go and without requiring a differential coloration. These 
images do not only show glomeruli, but even renal tubuli. The glomerular structure is very 
well defined, showing also the glomerular tuft in detail. Moreover, as underlined by the red 
rectangle on the bottom of Figure 4.4 C), a renal blood vessel and some erythrocytes inside 
are distinguishable. In Figure 4.4 D), the red arrow indicates a renal blood vessel linking to a 
very distinct glomerulus, and the presence of erythrocytes is very prominent. 
       
        
 
 
 
 
 
Figure 4.4: 2D Section of mouse kidney stained with WGA-AlexaFluo 488 conjugated (stock concentration 
1mg/ml, diluted 1:1000 in a final volume of 20 ml of solution) and imaged by CM, using a 20x objective in 
immersion oil and the 488 channel. A), B), C), D): different views from the same section. Scale bars A), B), 
C): 75µm. Scale bar D):100µm 
 
A 
C 
B 
D 
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In Figure 4.5, an example of double and differential staining is shown, in which both dyes 
stain in a specific way different structural elements. The WGA is linked to the renal tubuli as 
well as to the glomeruli, while the Cy7-PEI to the renal vessels and glomeruli as well. The 
image in overlay comes from the overlap of the two colours, which gives orange shading on 
the elements that absorb both of dyes. 
  
 
 
  
 
 
 
 
Figure 4.5: 3D Section of mouse kidney, 
double stained with WGA-Alexa Fluo 488 
conjugated (stock concentration 1mg/ml, 
diluted 1:1000 in a final volume of 20 ml of 
solution) and Cy7-PEI, imaged by CM, using a 
20x objective in immersion oil and both 488 
and 638 channels for WGA and Cy7-PEI 
detection respectively. A) Glomeruli and tubuli 
detected from the WGA staining. B) Glomeruli 
and renal blood vessels detected from the Cy7-
PEI staining. C) Image in overlay, represented 
by the orange areas (green plus red). Scale bars: 
100µm 
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Figure 4.6 displays glomeruli as well as afferent renal vessels and some blood capillaries in a 
very clear way. In A), the original view is shown, with a very low background noise level, 
whereas in B) the depth coding, indicating the depth reached. As indicated by the depth 
coding, different depths have been detected.  
 
 Figure 4.6: 3D Sections of mouse kidney, stained with Cy7-PEI-opt, 
acquired by CM, using a 20x objective in immersion oil and the 638 channel. 
A) and B) view, respectively without and with depth coding. As indicated 
from the depth bar on the right side of the image B), the depth reached is 220 
µm. This scale goes from the surface of the sample (0-80µm, in blue-light 
blue), middle part (80-200µm, in green-yellow-orange) up to the deepest part 
of the region (200-220µm, in red). Scale bars: 100µm. 
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Figure 4.7 is a result of the recently new installed Stage Overview feature. With that, it has 
been possible to image larger sections compared to the previous ones. This is one example, 
where in A) it is possible to visualise and easily distinguish many glomeruli linked to the 
renal blood vessels. A depth coding view is given in B), where the glomeruli have been 
detected in different points of depth, as indicated from the depth coding on the right side of 
the image. 
 
B 
A 
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Mouse Kidney: LightSheet Microscopy  
In Figure 4.8 a mouse kidney pole imaged by LSM is shown. The depth coding view 
describes the depth reached, equal to 1.4mm. The background noise is barely noticeable and 
the glomeruli are clear and distinguishable as single entities. This is a further confirmation of 
the efficacy of the use of Cy7-PEI combined to the ECi-based OTC. Figure 4.8 A) shows the 
whole pole, whereas in B) a zoomed in detail is given. 
 
Figure 4.7: Section of mouse kidney imaged by CM, using a 20x objective in immersion oil and the 
638 channel. A) 3D Tile Scan, acquired using the Stage Overview option from LasX software. B) 3D 
Tile Scan in depth coding. As indicated from the depth bar on the right side of the image, the depth 
reached is around 250µm. This scale goes from the surface of the sample (0-100µm, in blue-light blue), 
middle part (100-200µm, in green) up to the deepest part of the region (200-250µm, in yellow- red). 
Scale bars: 500µm 
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Figure 4.9 shows a mouse kidney pole, stained with halved concentration of Cy7-PEI 
(1.5mg/ml) and imaged by using LSM. Despite the reduction of the dye concentration, the 
glomeruli are anyway well visible and recognizable, with a very low background noise level. 
Moreover, this 3D image could be suitable also for counting and quantification. 
 
 
 
Figure 4.9: Depth coding view of a kidney pole from mouse (corresponding to 1/3 of the whole 
kidney) stained with Cy7-PEI in 1.5mg/ml as concentration and imaged by LSM, using a 5x 
objective in ECi, with 488 and 638 lasers. Total depth: 1.4mm. As indicated by the depth coding on 
the right side of the image, the scale goes from the surface (0.0-0.4mm, in blue-light blue); middle 
part (0.4-1.2mm, in green-yellow); deepest part (1.2-1.4mm, in orange-red). Scale bar: 1mm. 
Figure 4.8: Depth coding view of a kidney pole from mouse, imaged by LSM, using a 5x objective in ECi 
and 638 channel. A) Pole from mouse kidney (corresponding to 1/3 of the whole kidney) imaged for 1.4mm. 
As indicated from the depth coding on the right side of the images, the scale goes from the surface (0.0-
0.4mm, in blue), middle part (0.4-1.2mm, in green-yellow) up to the deepest part (1.2-1.4mm, in orange-red). 
Scale bar: 1mm. B) Detail from a zoom in view of the picture. Scale bar: 500µm. 
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Figure 4.10 (A and B) was acquired after perfusing with Cy7-PEI in 1mg/ml as concentration 
and clearing. Despite the strong reduction in concentration of the dye, the images clearly 
demonstrate the presence of blood renal vessels, to which some glomeruli are linked to. In 
figure A), the glomeruli are more sharp compared to B), although in both A) and B) it is 
possible to see truly “through” the renal blood vessels.  
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4.4.2 ECi-based OTC: different mouse samples 
In this section, images from female WT C57BL/6 mouse heart, lung, liver, spleen, will be 
shown. In the interest of simplicity and unless stated otherwise, all the images are intended 
acquired by CM after perfusion and staining with Cy7-PEI in 3mg/ml as concentration. 
Mouse Heart 
The 3D image shown in Figure 4.11 was acquired after perfusion with Cy7-PEI-opt 4F (4F: 
filtered 4 times) and stored in ECi for 26 days. Before the imaging, the thin section was 
mounted following the method b) described in the paragraph 4.3.1. As indicated by the depth 
scale in figure B), although only 60µm were imaged, a detailed set of cardiac blood vessel is 
Figure 4.10: Renal blood vessels from a mouse kidney pole stained with Cy7-PEI in 1mg/ml as 
concentration and imaged by LSM, using a 5x objective in ECi and 638 channel. Both images A) and B) 
show renal afferent artery, connecting to some glomeruli. Scale bars: 100µm 
 
Results   - 44 - 
 
clearly described. As revealed by this image, this is characterized by a big artery and its 
branches surrounded by several capillaries, which are very well defined and easy to follow. 
 
A 
Figure 4.11: Section of heart from mouse, stained by Cy7-PEI-opt 4F (3mg/ml) and imaged by CM, using a 
20x objective in immersion oil and 638 channel. A) 3D image. B) 3D image in depth coding. As indicated by 
the scale on the right side of the image, the scale goes from the surface (0-20µm, in blue-light blue); middle 
part (20-50µm, in green-yellow); deepest part (50-60µm, in orange-red). Scale bars: 50µm. 
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Mouse Lung 
Figure 4.12 (A, B, C) concerns another staining, made with nanoparticles, injected via 
intraperitoneal prior to the perfusion. In particular, the one which the images are referred to is 
the NP510N-Alexa647 conjugated (Thermofischer Scientific, Germany). The maximum 
absorbance and emission are, respectively, 651nm and 672nm; therefore, this is located in the 
NIR of the spectrum. These images show the alveolar structures as well as the blood vessels, 
which are well recognizable. Barely perceptible is the background noise level. 
B 
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Figure 4.12: Mouse lung imaged 
by CM, stained with NP510N-
Alexa647 conjugated, using a 
20x objective in immersion oil 
and 638 laser. A, B and C 
represent three different regions 
of the same section, in 2D. Scale 
bars: 100µm. 
Alevoli 
Alevoli 
A 
B 
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In Figure 4.13 a mouse lung, stained with WGA Alexa488 conjugated and imaged by CM is 
shown. A) and B) clearly display well defined 2D alveolar structures, whereas C) and D) 
represent the 3Ds, without and with depth coding respectively. Although, as indicated by the 
depth coding, the depth reached is not deep, all the pulmonary structures are well defined, 
both in 2D and in 3D. Even some bronchioles are recognizable. Moreover, in the whole 
pulmonary tissue, the background noise level is very low, demonstrating a) the good quality 
of the perfusion and b) the high efficacy of the ECi-based OTC. 
          
 
Alevoli 
Alevoli 
Alevoli 
PulmonaryBlood 
Vessel 
C 
A B 
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D 
C 
Figure 4.13: Section of mouse lung, stained with WGA-Alexa Fluo 488 conjugated (stock concentration 
1mg/ml, diluted 1:1000 in a final volume of 20 ml of solution) and imaged by CM, using a 20x objective in 
immersion oil and 488 channel. A) and B) represent two different regions of the same section, in 2D. Scale bars: 
100µm. C) 3D view. Scale bar 100µm. D) 3D depth coding view: As indicated by the scale on the right side of 
the image, this goes from the most superficial regions (0-20µm in blue-light blue), middle part (20-60µm in 
green-yellow) up to the deepest part (60-70µm, in red). Scale bar: 100µm. 
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Figure 4.14 shows a 3D mouse lung section, imaged by CM. The final depth reached is 
200µm. The imaging proceeded and captured structural elements in all the points of the depth. 
Alveoli are well distinguishable. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.14: 3D 
mouse lung section, 
imaged by CM, using 
20x objective in 
immersion oil and the 
638 channel. A) 3D 
Tile Scan. B) Depth 
coding view: As 
indicated by the scale 
on the right side of the 
image, this goes from 
the most superficial 
regions (0-80µm in 
blue-light blue), 
middle part (80-180µm 
in green-yellow) up to 
the deepest part (180-
200µm, in orange- 
red). Scale bars: 
200µm 
A 
B 
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Mouse Spleen  
Figure 4.15 represents the 2Ds of two different regions of the same spleen mouse sample. The 
main elements in there are the white and red pulps, underlined, respectively by the black 
round shape and black arrow. These are differentiated by the diverse brightness intensity. 
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Mouse Spleen: Light Sheet Microscopy 
The depth coding version of Figure 4.16 shows a very large section of mouse spleen imaged 
by LSM. Thanks to the longer working distance of the objective, a very wide depth was 
achieved. Additionally, this image shows also some structural details as white and red pulp.  
 
Figure 4.15: Spleen section from mouse, imaged by CM, using a 20x objective in immersion oil and 
the 638 channel. A) and B) show different regions of the same section in 2D. Scale bars: 25µm 
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Figure 4.16: Spleen section from mouse, imaged by LSM, using a 5x objective in ECi and the 638 channel. 3D 
Tile scan view in depth coding. As indicated by the scale on the right side of the image, this goes from the most 
superficial region (0.0-0.6mm in blue-light blue), middle part (0.6-1.2mm in green-yellow) up to the deepest part 
(1.2-1.4mm, in orange- red) Scale bar: 2mm 
 
 
Figure 4.17 shows a mouse spleen, stained with halved concentration of Cy7-PEI (1.5mg/ml). 
Despite the reduction in concentration of the dye, all the main spleen structural elements are 
easily detectable. In fact, from the outside it is possible to identify the connective capsule, 
surrounding all the spleen. Within, the main components of this organ: the white and red pulp: 
this latter is viewable as a set of red dots. In that it is present the connective tissue, known as 
cords of Billroth and a spleen artery clearly visible with its branches. 
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Figure 4.17: 2D mouse spleen section stained with Cy7-PEI in 1.5mg/ml and imaged by LSM, using a 5x 
objective in ECi and the 638 channel. Scale bar: 100µm 
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Mouse Liver 
In Figure 4.18 another example of 3D mouse liver, imaged by CM, is shown. Sinusoids and 
hepatocytes are clearly distinguishable. These are underlined by the light-green arrows. 
Figure B) is the depth coding view. 
 
 
 
 
 
 
Sinusoid 
Hepatocytes 
A 
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A further example of the imaging of mouse liver is given by Figure 4.19: A) shows in 2D all 
the main hepatic tissue elements (indicated in the figure). In addition to the central vein, 
sinusoids and hepatocytes, also an artery is shown. B) and C) are the 3Ds, with and without 
depth coding, respectively. The depth reached is 140µm. 
Figure 4.18: Liver section from mouse, imaged by CM, using a 20x objective in immersion oil and the 638 
channel. A) 3D view. Scale bar: 200µm. B) 3D view in depth coding: as indicated by the scale on the right 
side of the image, this goes from the most superficial region (0-40µm in blue-light blue), middle part (40-
100µm in green-yellow) up to the deepest part (120µm, in red) Scale bar:200µm 
 
 
Scale bar: 200µm 
 
B 
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Figure 4.19: Mouse liver section, imaged by CM, using a 20x objective in immersion oil and the 638 channel. 
A) 2D view. Scale bar: 25µm. B) 3D view. C) 3D view in depth coding: as indicated by the scale on the right 
side of the image, this goes from the most superficial region (0-40µm in blue-light blue), middle part (40-120µm 
in green - yellow) up to the deepest part (120-140µm, in red) Scale bars: 200µm 
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4.4.3 ECi-based OTC: Results from pathological samples 
In order to understand whether the ECI-based OTC would have been suitable also on 
pathological samples, in the following some results from rat samples, characterized by 
different diseases, will be reported.  
CISPLATIN RAT 
As part of the project G14/13, carried out by Cristina Daniele, under the supervision of Prof. 
Dr. med. N. Gretz, some kidneys from male Sprague Dawley (SD) rats, treated with cisplatin 
(TEVA, 1mg/ml ready to use solution; used in a dose of 7mg/kg BW) in order to cause kidney 
injury, were provided to be cleared and imaged. Prior to the perfusion, the rats were treated by 
injections of cisplatin. As it is described in Table 4.6, the perfusion procedure, performed 
after 14 days from the first injection of cisplatin, was slightly modified, as the timing and the 
pressure used were adapted for rats, although the injection of the dyes were kept to the same 
rate as previously described (1ml/min). For these experiments a double staining was used, 
made with WGA and Cy7-PEI. The working concentrations for both dyes were kept the same 
as usual. 
REAGENT TIME 
(min) 
PRESSURE(mbar) 
NaCl pH 7.4+ 
hep 
3 280 
Cy7-PEI 1 230 
NaCl pH 7.4+ 
hep 
1 230 
WGA 1 230 
NaCl pH 7.4+ 
hep 
1 230 
4% PFA 3 230 
Table 4.6: Perfusion protocol used for SD rats. 
 
In order to assess whether it could have been possible to use the CM technology to analyze in 
depth the main elements of cisplatin-induced AKI, the following images were acquired during 
the animal model establishment phase. Figure 4.20 (A, B, C) shows many hallmarks of the 
cisplatin-induced AKI, mentioned before. First of all, a very high level of macrophage 
infiltrate is present (represented by the green dots), detected in all of the three images. Tubular 
dilatation is also distinguishable. In addition, noticeable is the result of this differential. In 
fact, in A), the more visible elements are the renal tubuli and the macrophages, stained by 
WGA, while in B) the glomeruli are more easily detectable. This is in accordance with the 
different role of the two dyes: WGA is a lectin and it links to N-acetylnerumaninc acid, as 
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components of carbohydrates from cell membranes, which is, in turn, a prominent component 
of the macrophages. On the other hand, as already explained, Cy7-PEI was designed to bind 
directly to the glomeruli and blood vessels. Figure 4.20 C) shows the overlay between the two 
dyes, where the orange shades come from their overlapping. Again, even in the image in 
overlay, the macrophages are only green colored. 
 
A 
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In Figure 4.21 another example of the differential staining, performed with WGA and Cy7-
PEI is presented. Again, a very high rate of inflammatory infiltrates (represented by the green 
dots) is highlighted, while the glomeruli are characterized by orange shades, as result of the 
combination of both dyes. In C), although no renal tubular dilatation is revealed, the presence 
of the macrophages is still high. The glomerulus, on the right side, is again in orange shade, as 
sign of overlay of the two dyes. 
 
 
 
C 
Figure 4.20: 2D Kidney section from SD rat, treated with cisplatin injection prior to perfusion and OTC, 
stained with WGA Alexa Fluo488 conjugated (stock concentration 1mg/ml, diluted 1:1000 in a final volume 
of 20 ml of solution) and Cy7-PEI, imaged by CM, using a 20x objective in immersion oil. All of the three 
images are from the same region, where A) shows WGA detection only, with 488 channel; B) Cy7-PEI 
detection only, with 638 channel and C) overlay image. Scale bars: 75µm  
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C 
Figure 4.21: 2D Kidney section from SD rat, treated with cisplatin injection prior to perfusion and OTC, stained 
with WGA-Alexa Fluo488 conjugated (stock concentration 1mg/ml, diluted 1:1000 in a final volume of 20 ml 
of solution) and Cy7-PEI, imaged by CM, using a 20x objective in immersion oil. The 488 channel was used for 
imaging the WGA staining and the 638 channel for the CY7-PEI staining. A), B), C): Images in overlay. Scale 
bars: 75µm 
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ADPCK Rat 
As part of the project G19/17, carried out by Daniela Nardozi, under the supervision of Prof. 
Dr. med. N. Gretz, some 10 months old female ADPCK rat kidneys were provided to be 
cleared and imaged. As described in Table 4.7, the perfusion procedure was slightly modified, 
as the timing and the pressure used were adapted for rats, although the injection of the dyes 
were kept to the same rate as previously described (1ml/min). For these experiments a double 
staining of WGA and Cy7-PEI was used. The working concentrations of both dyes were kept 
the same as usual. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.22 underlines the presence of some renal cysts (indicated by yellow arrows), 
different in their appearance. In fact, the different appearance of the cysts depends on their 
different content, which might be rich in extracellular matrix, proteins or lipids. Based on that, 
these can appear “full” or “empty”. Furthermore, the tubular damage is emphasized by the de-
differentiated epithelium. On the left side of the figure, an orange coloured glomerulus is 
located. This is the result of the overlay of the two dyes, which is more prominent in some 
structures than in others. In fact, differently from the glomerulus, the cyst content is not the 
specific Cy7-PEI marker and this is the reason why the renal cysts appear only in green 
coloured, as the result of the only WGA staining.  
 
REAGENT TIME 
(min) 
PRESSURE(mbar) 
NaCl pH 7.4+ hep 3 280 
Cy7-PEI 1 230 
NaCl pH 7.4+ hep 1 230 
WGA 1 230 
NaCl pH 7.4+ hep 1 230 
4% PFA 3 230 
Table 4.7: Perfusion protocol used for PCK rats. 
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Figure 4.22: 2D Kidney section from PCK rat, stained with WGA-Alexa Fluo488 conjugated (stock 
concentration 1mg/ml, diluted 1:1000 in a final volume of 20 ml of solution) and Cy7-PEI, imaged by CM, using 
a 20x objective in immersion oil. Channel 488 and 638 used to detect, respectively, the WGA and the CY7-PEI 
staining. Image in overlay. Scale bar: 75µm  
 
 
In Figure 4.23 all the distinctive traits of PCK disease are shown. On the bottom of the image 
a glomerulus with enlarged Bowman’s space is visible, as well as cysts, indicated by yellow 
arrows. The tubular epithelium layer appears de-differentiated and, additionally, there is a 
clear loss of the normal tubular conformation. Concerning the staining, this image confirms 
once again the differences between WGA and Cy7-PEI. Only the two glomeruli appear in 
orange shadows, as sign of overlay of both dyes, whereas, cysts and renal tubuli are 
completely green, as result of non-specific markers for the Cy7-PEI. Moreover, the 
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glomerulus depicted in the left upper part of the image (in the red circle) shows only a partial 
overlay. This is due to a lack of perfusion, which, in turn, might depend on two factors: in 
fact, this could be a sign either of a glomerular sclerosis or a mesengial expansion. 
 
 
Figure 4.23: 2D Kidney section from PCK rat, imaged by CM, using a 20x objective in immersion oil. Channel 
488 and 638 used to detect, respectively, the WGA and the CY7-PEI staining. Image in overlay. Scale bar: 75µm 
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In Figure 4.24 the 3D image is shown. On the right side of the picture, a big renal cyst 
(indicated by the pink arrow) is depicted and the renal tubuli, surrounding the two glomeruli 
in there, are clearly de-differentiated. Once again, the overlay between the two dyes regards 
only the glomeruli, appearing in the usual orange shadow. 
 
 
 
 
 
 
 
4.5 Different staining: H&E Staining 
In order to analyse the fluorescence provided by the H&E staining and combine that with CM 
microscopy, some mouse, rat and human not cleared kidney slides were stained using the 
standard procedure which is normally performed for 5µm slides and then imaged by CM. 
Furthermore, whole mouse organs were perfused with H&E, cleared by the ECi-based OTC 
procedure and microscopically analysed. This paragraph will show first the images acquired 
Figure 4.24: 3D Kidney section from PCK rat, stained with WGA-Alexa Fluo488 
conjugated (stock concentration 1mg/ml, diluted 1:1000 in a final volume of 20 ml of 
solution) and Cy7-PEI, imaged by CM, using a 20x objective in immersion oil. Channel 488 
and 638 used to detect, respectively, the WGA and the Cy7-PEI staining. Image in overlay. 
Scale bar: 200µm 
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on the slides and then on the whole organs. Unless stated otherwise, the mouse strain refers to 
C57BL/6, while the rat strain refers to SD. The human samples came from renal biopsies, 
provided by the Pathology Department of Universitäts Klinikum of Mannheim. 
MOUSE SLIDES  
Figure 4.25 shows a 3D image of a 5µm mouse slide stained with H&E and analysed through 
CM. The green colour (488 channel) refers to the eosin, whereas the red colour (552 channel) 
to haematoxylin. Glomeruli, surrounded by renal tubuli, are immediately evident. Moreover, 
the red dots within the tubuli are nuclei from the epithelial cells, which are also present in the 
glomeruli. So, as expected from this staining, both dyes were detected in the right place. 
 
 
 
 
 
 
Figure 4.25: Mouse slide (5µm), stained with H&E and imaged by CM using a 20x 
objective in immersion oil 488 plus 552 channels, respectively for eosin and haematoxylin 
detection. Sample not cleared. 3D Image in overlay. Red colour refers to haematoxylin 
and green colour to eosin. Scale bar: 200µm. 
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Figure 4.26 shows a 3µm slide stained by using the H&E protocol from the Pathology 
Department of the Universität Klinikum of Mannheim. For this imaging, purple colour (552 
channel) was used to detect haematoxylin and orange colour (488 channel) eosin. The pinkish 
gradation is the result of the overlay of both dyes. As expected from the standard visualisation 
of this staining, the nuclei of epithelial cells are purple coloured, whereas the tubuli appear in 
orange shadow. However, as a not cleared sample, the detection of blood vessels as well as 
other inner structures was not possible. 
 
 
 
 
 
 
 
 
 
 
Figure 4.26: Slide of a mouse kidney of 3µm in thickness, stained with H&E (Pathology Department 
protocol – see Material and Methods, Tab.3.2b) and imaged by CM, using a 20x objective in immersion oil 
and 488 plus 552 channels, respectively for eosin and haematoxylin detection. Sample not cleared. 2D Image 
in overlay, where purple colour refers to haematoxylin, orange colour to eosin and the pinkish gradation is 
the result of the overlay of the two channels. Scale bar: 250µm. 
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RAT SLIDES 
Figure 4.27 illustrates the results obtained from the CM imaging of a 5µm rat kidney slide. 
This is a 2D image. The red colour (488 channel), in A) refers to the eosin the purple colour 
(552 channel) in B) to the haematoxylin and the magenta shadow in C) is the overlay of the 
A) and B). Especially in A) and C) a whole glomerulus surrounded by tubules is evident. 
Moreover, Figure 4.27 A) displays the surface of the tissue structures, as expected from a 
standard visualisation in a normal microscope and the cellular nuclei are displayed as dark 
dots, as result of the negative contrast. These are better revealed in B), where the only 
haematoxylin detection is shown. Also the overlay underlines the presence of cellular nuclei 
within the glomerulus, in particular where the haematoxylin intensity is stronger. In addition 
it is important to underline the lack of clearing, which is the reason why only superficial 
structures were detected. Despite that, a renal blood vessel is clearly recognizable, as 
indicated by the yellow arrows. 
 
 
Figure 4.27: 2D Slide of a rat 
kidney of 5µm in thickness, 
stained with H&E and imaged by 
CM, using a 20x objective in 
immersion oil and 488 plus 552 
channels, respectively for eosin 
and haematoxylin detection. 
Sample not cleared. A) Image 
acquired by 488 channel only, for 
eosin detection. B) Image 
acquired by 552 channel only, for 
haematoxylin detection. C) Image 
in overlay. Scale bars: 50µm 
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HUMAN SAMPLES 
This section will examine the results obtained from the imaging of human kidney slides with 
CM. Figure 4.28 A) and B) show human glomeruli in detail. A closer look underlines cellular 
nuclei, here represented as dark dots, due to the negative contrast coming from the overlay. A 
wider Bowman’s space is well recognisable. The renal tubuli around the glomeruli are easily 
detectable and the overlay provides a better visualisation of all the structures. Being a not 
cleared tissue, no inner structure is displayed. In addition, Figure 4.28 A) highlights also the 
presence of some fibrotic tissue (indicated by the yellow arrow). 
 
Figure 4.28: 2D Kidney section 
(50µm) from human renal 
biopsy, stained with H&E and 
imaged by CM, using a 20x 
objective in immersion oil and 
488 plus 552 channels, 
respectively for eosin and 
haematoxylin detection. Sample 
not cleared. Both A) and B) are 
images in overlay, where the 
purple colour refers to 
haematoxylin and the orange one 
to eosin. The overlay generates a 
magenta colour. Scale bars: 
75µm 
 
 
 
 
A 
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The following images (Fig.4.29, Fig.4.30) will be focused on WT C57BLK/6 mouse samples, 
perfused with a combination of H&E and Cy7-PEI (protocol description in Tab. 4.8), then 
cleared by the ECi-based OTC and, afterwards, imaged by CM. The Cy7-PEI working 
concentration was kept to 3mg/ml and all dyes were injected in the usual ratio of 1ml/min. 
REAGENT TIME 
(min) 
PRESSURE (mbar) 
NaCl pH 7.4+ hep 6 180 
Cy7-PEI 10 180 
NaCl pH 7.4+ hep 1 
180 
Hemtoxylin 5 180 
NaCl pH 7.4+ hep 1 180 
Eosin 5 180 
NaCl pH 7.4+ hep 1 180 
4% PFA 6 180 
Table 4.8: Perfusion protocol used for the triple staining on C57BL/6 mouse 
 
B 
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After the perfusion, kidneys and lungs were collected, cleared and microscopically analysed. 
Two purposes aimed this experiment: 
a) Firstly, to figure out whether other dyes, in addition to Cy7-PEI, would have survived 
the ECi OTC; 
b) Secondly, to evaluate whether the H&E staining could have provided a differential 
staining also on 3D objects; 
c) Lastly, to understand whether the H&E combined to Cy7-PEI could have given 
additional information for the 3D imaging. 
The following images will show the results concerning the aforementioned protocol. 
 
In Figure 4.29, a mouse kidney stained with the aforementioned perfusion protocol is shown. 
The orange colour (488 channel) in A) refers to eosin, purple colour (552 channel) in B) to 
haematoxylin, red colour (638 channel) in C) to Cy7-PEI and the magenta shade in D) is the 
result of the overlay of the all channels. The analysis through CM pointed out that all dyes 
survived the OTC procedure. Despite that, a differential staining was only partially possible. 
In fact, due to the perfusion which allows the staining of the whole animal body, although all 
dyes contributed to stain all tissue structures, the specific markers of each single dye are 
clearly viewable from the images. In fact, the eosin channel in A) distinctly shows renal 
tubuli, which are the proper eosin marker; in addition to that, the haematoxylin channel in B) 
depicts also some cellular nuclei and the Cy7-PEI channel in C) contributes to the glomeruli 
staining to a larger extent compared to the previous ones. In D), where the overlay is 
reproduced, a whole set of these structures is represented. It is important to underline the 
overlapping phenomenon in the same region of the spectrum between all dyes. For instance, 
haematoxylin and Cy7-PEI share part of that, creating, therefore, a sort of masking effect. 
This could be a reason why a partial differential staining occurs. 
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Figure 4.29: 2D mouse 
kidney section, perfused by 
Cy7-PEI and H&E. Image 
acquired by CM, using a 
20x objective in immersion 
oil and 488, 552 and 638 
channels, respectively for 
eosin (A), haematoxylin (B) 
and Cy7-PEI (C) detection. 
Scale bars: 75µm. D) Image 
in overlay. Scale bar: 50µm 
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Figure 4.30 illustrates a mouse lung. As previously described, the orange colour (488 channel) 
in A) refers to eosin, purple colour (552 channel) in B) to haematoxylin, red colour (638 
channel) in C) to Cy7-PEI and the magenta shade in D) is the result of the overlay of the all 
channels. Even in this case all dyes survived to the ECi-based OTC. Although, as previously 
described, only a partial staining was possible the main pulmonary structures, as alveoli and 
the pulmonary artery are detectable.  
 
Figure 4.30: 2D mouse lung section, perfused by Cy7-PEI and H&E. Image 
acquired by CM, using a 20x objective in immersion oil and 488, 552 and 
638 channels, respectively for eosin (A), haematoxylin (B) and Cy7-PEI (C) 
detection. D) Image in overlay. Scale bars: 100µm 
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4.6 Shrinkage Studies  
The following paragraph will describe the results obtained by comparing the optimised (Opt) 
and the original protocol (Org
52
). After mouse perfusion, kidneys, heart, liver, lung and spleen 
were collected and the following parameters were analysed before and after the two different 
procedures (for all the details refer to Material and Methods): weight, surface area, volume 
and lipid content, in order to asses which of the two ECi-based OTC protocols could generate 
the more shrinkage. The following graphs (Fig. 4.31, 4.32, 4.33, 4.34) illustrate the results 
obtained from these studies. 
Figure 4.31 relates to the weight results. Except for lungs, all the other organs exhibit a 
decrease in weight after both protocols: heart: -0.065g (Opt), -0.132g (Org); kidney: -0.059g 
(Opt), -0.11g (Org); liver: -0.34g (Opt), -0.47g (Org); spleen: -0.042g (Opt), - 0.053g (Org). 
On the other hand, lung seems to gain weight after both the procedures: +0.065g (Opt), 
+0.015g (Org). 
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Figure 4.32 shows the surface area comparisons between Opt and Org protocol. As described 
in the following graph, for the surface area a decrease was noticed after both the procedures, 
for all organs except for lung after Org. The changes are the following: heart: -26.83% (Opt), 
-55.93% (Org); kidney: -26.83% (Opt), -55.93% (Org); liver: -36.12% (Opt), -46.91% (Org); 
lung: -56.79% (Opt), +49.83 (Org), spleen: -13.13% (Opt), -70.19% (Org). 
Figure 4.31: Shrinkage analysis of different organs based on weight (manual). 
Bar plot show the weight comparison between our optimized (blue bar) and the original 
protocol (red bar). The values are the results from differences obtained by calculating the 
weight before and after the OTC procedure, for both protocols and for all the organs. The 
weight values are expressed in g. Asterisks indicate significance (p < 0.05) in a paired t test 
between the two protocols, error bars denote SD. The sample size is n = 5. 
Results   - 81 - 
 
 
 
 
 
 
 
 
 
 
Figure 4.33 regards the volume values, obtained from the two different ECi-based OTCs.  
Very important differences were observed. In fact, for heart and kidney, liver and lung a very 
high decrease in the volume is present after the original procedure when compared to the 
optimised one: heart: -26.16% (Opt), -86.80% (Org); kidney: -59.60% (Opt), -85.06% (Org); 
liver: -35.52% (Opt), -89.09% (Org); lung: -82.22% (Opt), -44.82% (Org). The opposite 
situation was found in spleen, which seems to decrease its volume more in the optimised 
protocol than in the original: spleen: -70.69% (Opt), -55.35% (Org).  
Figure 4.32: Shrinkage analysis of different organs based on surface area (manual). 
Bar plot show the surface area comparison between our optimized (blue bar) and the 
original protocol (red bar). The values are the results from differences obtained by 
calculating the surface area before and after the OTC procedure, for both the protocol 
and for all the organs. Afterwards, the values were normalized to fixed percentage 
(100%) for organs before clearing. The surface area values are expressed in percentages. 
Asterisks indicate significance (p < 0.05) in a paired t test between the two protocols, 
error bars denote SD. The sample size is n = 3. 
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Figure 4.34 presents the results concerning the lipid content. Both OTC protocols contribute 
to the lipid extraction in the same way. In fact, none of the t-tests performed gave a significant 
result (p > 0.05). A reduction of the lipid contents occurred almost equally in both procedures: 
heart: -87.29% (Opt), - 91.23% (Org); kidney: -92.09% (Opt), -92.55% (Org); liver: -94.42% 
(Opt), -88.88% (Org); spleen: -86.96% (Opt), -86.65% (Org); lung: -94.99% (Opt), - 85.63% 
(Org).  
Figure 4.33: Shrinkage analysis of different organs based on volume (manual). 
Bar plot show the volume comparison between our optimized (blue bar) and the original protocol (red bar). The 
values are the results from differences obtained by calculating the volume before and after the OTC procedure, 
for both the protocol and for all the organs. Afterwards, the values were normalized to fixed percentage (100%) 
for organs before clearing. The volume values are expressed in percentages. Asterisks indicate significance (p < 
0.05) in a paired t test between the two protocols, error bars denote SD. The sample size is n = 5. 
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4.7 Dye Stability 
In order to evaluate and prove the stability of the fluorescent dyes, after a long time (years), in 
ECi, three different imaging were performed on the same mouse kidney sample with an 
interval of 2 and 3 years, as shown in Figures 4.35, 4.36, 4.37. The staining was Cy7-PEI-opt 
4F in 3mg/ml as concentration. Before going on with the imaging, the sample was stored for 
48 hours in 88% glycerol for the RI correction. Figure 4.35 A) displays a 2D picture, 
revealing a differential staining, as result of a combination of the dye itself (red colour) and 
the autofluorescence (green colour). Thanks to that, in fact, it was possible to detect all the 
Figure 4.34: Shrinkage analysis of different organs based on lipid content (fluorescent 
assay). Bar plot show the lipid content comparison between our optimized (blue bar) and the 
original protocol (red bar). The values are the results from differences obtained by 
calculating the lipid content before and after the OTC procedure, for both the protocol and 
for all the organs. Afterwards, the values were normalized to fixed percentage (100%) for 
organs before clearing. The lipid content values are expressed in percentages. Error bars 
denote SD. The sample size is n = 5. 
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structures, even the ones which are not detectable by Cy7-PEI-opt 4F. In green, renal tubuli 
are visible, whereas glomeruli are in a colour range between red and yellow, as result of an 
overlay of the two channels. The 3D image in depth coding in B) proves the detection of 
structures in different points of depth.  
  
 
 
A 
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Figure 4.35: Section of mouse kidney imaged by CM, stained by Cy7-PEI-opt in 3mg/ml as concentration, using 
a 20x objective in 88% glycerol and 488 plus 638 channel to respectively detect autofluorescence and Cy7-PEI-
opt 4F. A) 2D section. Scale bar: 100µm. B) 3D section in depth coding. The depth bar on the right side of the 
image indicates the depth reached during the imaging: it goes from the surface (0-40µm, in blue-light blue), the 
middle area (40-100µm, in green-yellow) up to the deepest parts (100-120µm, in orange-red).Scale bar: 200 µm 
 
 
Figure 4.36 regards the same mouse kidney from Figure 4.35, which was imaged after 2 
years. Except for the detection of the autofluorescence and the use of the Stage Overview, 
which gave a big amelioration, other experimental conditions were kept equal to the first 
imaging. Compared to Figure 4.35, it was possible to a) go more in depth, and b) acquire a 
larger region of interest. Here, 3D images in depth coding are presented. Despite a little loss 
of structural data, due to the loss of fluorescence in the time and a little increase of the 
background noise level, it is however noticeable the presence of the dye, still surviving after 
two years from the first imaging. 
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Figure 4.37 is the results obtained from the same mouse kidney, imaged in the same 
conditions (including the detection of the autofluorescence), after 3 years. Surprisingly, the 
dye was still in place, despite a further loss of fluorescence, due to the time. In red some 
glomeruli and renal blood vessels are visible (from the Cy7-PEI-4F detection), whereas in 
green tubuli (from autofluorescence detection). Orange shadows come from the overlay of the 
two dyes. Because of the loss of the fluorescent signal and as indicated by the depth coding in 
Figure 4.37 B), the total depth detected was reduced compared to Fig. 4.36.  
Figure 4.36: Kidney pole from mouse, imaged by CM, stained with Cy7-PEI-opt 4F in 3mg/ml as 
concentration using 20x objective in 88% glycerol and the 638 channel. 3D Tile Scan. This image was 
acquired by using the Stage Overview option from Las-X software (Tiles number: 15). View in depth coding 
from top A) and in front B). Scale bars: 500µm. C) Detail in depth coding from top showing some glomeruli 
and renal vessels. Scale bar: 100µm. As indicated from the depth bar on the right side of the images, the 
depth reached is around 500µm. This scale goes from the surface of the sample (0-150µm, in blue-light 
blue), middle part (100-400µm, in green-yellow) up to the deepest part of the region (400-450µm, in yellow-
red).  
 
C 
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Figure 4.37: Kidney pole from mouse, stained with Cy7-PEI-opt 4F in 3mg/ml as concentration, 
imaged by CM, using 20x objective in 88%glycerol with 488 and 638 channel to detect respectively 
autofluorescence and Cy7-PEI-opt 4F. 3D Tile Scan. This image was acquired by using the Stage 
Overview option from Las-X software (Tiles number: 12). A) Scale bar: 500 µm. B) Depth coding 
view. As indicated from the depth bar on the right side of the images, the depth reached is around 
300µm. This scale goes from the surface of the sample (0-100µm, in blue-light blue), middle part (100-
200µm, in green) up to the deepest part of the region (200-250µm, in yellow-red). Scale bar: 500 µm 
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4.8 Alternative Uses of Eci-based OTC  
4.8.1 De-Paraffinization and clearing of paraffin blocks 
This section describes the results from the protocol mentioned in the paragraph 3.5.1. PCK rat 
kidneys, lungs and heart from 20 years old paraffin blocks as well as human kidney biopsies 
obtained after nephrectomy were tested and treated. 
Polycystic Rat 
Figure 4.38 shows very well detectable structural elements, even in absence of a specific 
staining. As a PCK rat, renal cysts are prominent, as indicated by the red arrows both in A) 
and in B). Moreover, it is also possible to recognize a very de-differentiated tubular 
epithelium, which is a characteristic of this pathology. The yellow arrow indicates also a 
glomerulus surrounded by an enlarged Bowman’s space, another clear sign of the disease. 
 
 
 
 
 
A 
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The images shown in Figure 4.39 A), B) and C) were acquired after de-paraffinisation and 
clearing of 20 years old paraffin embedded sample: surprisingly, the inner structures survived 
the whole protocol. In fact, these images show the glomeruli and renal tubuli with a very low 
background noise level. Remarkable is also the depth reached, considering the age of the 
paraffin block. The zoomed in glomerulus shown in C) depicts a much enlarged Bowman’s 
capsule, clear sign of this pathology. 
B 
Figure 4.38: 2D Kidney section from a PCK rat, imaged by CM, using a 20x objective in 
immersion oil. No staining. Autofluorescence detected by 488 channel. A) 2D view. 
Scale bar: 100µm. B) Zoomed in view of A). Scale bar: 50µm 
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Figure 4.39: A de-paraffinised and cleared section from a PCK kidney rat. The original paraffin block was 
made in 1998 and further processed in 2018. Imaging acquired by CM, using a 20x objective in immersion oil 
and 488 channel for autofluorescence detection. A) 3D image. Scale bar: 200µm. B) 3D view in depth coding: 
as indicated by the scale on the right side of the image, this goes from the most superficial region (0-100µm in 
blue-light blue), middle part (100-200µm in green) up to the deepest part (200-250µm, in yellow-red). Scale 
bar: 200µm. C) 2D zoomed in view of a glomerulus Scale bar: 25 µm. 
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After the clearing procedure and before the imaging, the PCK rat lung shown in Figure 4.40 
was stored in ECi for 6 days and, furthermore, imaged by CM using only autofluorescence for 
structures detection. The 3D images in A) and B) show the pulmonary artery and all the 
alveolar structures, indicated in the figure. Figure 4.40 C) underlines, in 2D, also the presence 
of some erythrocytes, which have their own strong autofluorescence. 
 
Results   - 95 - 
 
 
 
 
 
Results   - 96 - 
 
 
 
 
 
 
 
 
 
 
 
 
ERYTHROCYTES 
C 
Figure 4.40: A de-paraffinised and cleared section from a PCK rat lung. The original block was made in 1999 
and further processed in 2019. Imaging acquired by CM, using a 20x objective in immersion oil and 488 
channel for autofluorescence detection. A) Scale bar: 200µm. B) 3D view in depth coding: as indicated by the 
scale on the right side of the image, this goes from the most superficial region (0-100µm in blue-light blue), 
middle part (100-300µm in green - yellow) up to the deepest part (300-350µm, in orange-red). Scale bar: 
200µm. C) Zoomed in view of the pulmonary artery, with erythrocytes in there. Scale bar: 25µm 
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Figure 4.41 depicts a de-paraffinised and further cleared slice of heart from a PCK rat. After 
the clearing protocol and before the imaging, the sample was stored 3 days in ECi. Only 
autofluorescence was used to detect the structures. As indicated by the red arrows, it is 
possible to easily and clearly distinguish muscle fibres as well as erythrocytes. 
 
 
 
 
 
 
Human Kidney 
In collaboration with the Pathology Department of the Universitäts Klinikum of Mannheim, 
some human kidneys were obtained to be de-paraffinised and treated with ECi-based OTC, as 
shown in Figure 4.42. After a nephrectomy, a paraffin block was prepared. Furthermore, it 
was de-paraffinised and made ready for the OTC, but without staining. Nevertheless, the only 
autofluorescence detection allowed the visualisation of some renal structure. In fact, in A), it 
is possible to visualise a glomerulus and its Bowman’s space, which is enlarged because of 
Figure 4.41: A de-paraffinised and cleared slice from a PCK heart rat. The original block was made in 
1999 and further processed in 2019. Imaging acquired by CM, using a 20x objective in immersion oil 
and 488 channel for autofluorescence detection. Scale bar: 10µm 
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the disease. Even a set of tubules is recognisable. In B), “empty” cysts and renal tubuli are 
displayed.  
 
A 
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4.8.2 ECi removal and 3D Immunohystochemistry 
In the following paragraph, images regarding ECi removal by high ethanol concentrations, 
followed by rehydration and further 3D-IHC, will be listed and described. All the following 
images will report results obtained following the protocol described in the paragraph 3.5.2. 
After proceeding with ECi removal by high ethanol concentrations and further rehydration, 
3D-IHC was performed. 
B 
Figure 4.42: Human kidney section, from human kidney biopsy. After de-paraffinisation and clearing, 
this was imaged by CM, using a 20x objective in immersion oil and 488 channel for autofluorescence 
detection. A) Glomerulus and enlarged Bowman’s space. Scale bar: 50µm. B) A set of renal tubuli and 
empty cysts. Scale bar: 100µm 
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Figure 4.43 A) and B) reports the results obtained by the imaging of 1mm slide from mouse 
kidney stained with an antibody against nephrin as primary and Anti Goat Secondary 
Antibody AlexaFluo 647 conjugated. Figure 4.43 A) defines a tile scan, where the red colour 
refers to AlexaFluo 647 detection, which worked to identify glomeruli, in high number, for a 
total depth of 350µm (depth coding not shown). The autofluorescence was useful to 
distinguish the renal tubuli, and, in this way, a good combination for the visualization of all 
main structures was obtained. In B), the glomerulus is very distinct: the slit membrane is well 
structured and recognisable. Although not completely defined, this is surrounded by renal 
tubuli, in which, by a negative contrast some cells nuclei are also easy to follow. 
 
A
S 
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Figure 4.44 A) and B) presents the results of a second experiment, performed keeping the 
same experimental setup as the previous one. As in the previous images, the glomeruli (in 
red) are evident and well-shaped and the renal tubuli were detected by autofluorescence (in 
green). Within them, it is also possible to recognize epithelial cells nuclei, represented as dark 
dots, due to the negative contrast. 
B 
Figure 4.43: Mouse kidney section (1mm) cleared and rehydrated to remove the ECi, 
stained with primary antibody against nephrin and Chicken Anti Goat Secondary 
Antibody-AlexaFluo 647 conjugated. This was imaged by CM, using a 20x objective 
in 88% glycerol and 638 and 488 channels, respectively for AF647 and 
autofluorescence detection. A) Tile scan of the whole section. Scale bar: 1mm. B) A 
zoomed in view from A), where a glomerulus is displayed. Scale bar: 8µm 
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In Figure 4.45 results concerning nuclear staining are reported. In fact, in the following 
images, in addition to glomeruli, nuclei from epithelial cells were stained. In A) the results 
from the only nuclear staining (made with SytoxTM Green) are presented; in B) the red channel 
(anti-nephrin AlexaFluo 647 conjugated) related to the only glomeruli and in C) the overlay is 
depicted. However, due to the same wavelength spectrum range between autofluorescence 
and SytoxTM Green, it was possible to detect and reveal also renal tubuli, providing an almost 
complete overview regarding all the renal structures. In addition, the background noise level 
is very low, demonstrating the high specificity of both staining. The 63x objective was 
required in order to obtain a better quality of the cellular nuclei, which are completely visible 
and detectable. The total depth reached (here not shown) is equal to 90µm. This value is 
significantly lower than the depth reached in other images and this is due to the working 
distance of the 63x, equal to 0.14mm. 
Figure 4.44: Mouse kidney section (1mm) cleared, rehydrated to remove ECi, stained with primary 
antibody against nephrin and Chicken Anti Goat Secondary Antibody AlexaFluo 647 conjugated. 
This was imaged by CM, using a 20x objective in 88% glycerol and 638 and 488 channels, 
respectively for AlexaFluo 647 and autofluorescence detection. A) Scale bar 100µm. B) Zoomed in 
view from A). Scale bar: 10µm  
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Figure 4.45: 3D Mouse kidney 
section (1mm) cleared, 
rehydrated and stained with 
primary antibody against nephrin, 
chicken anti goat secondary 
antibody AF647 conjugated and 
counterstained with Sytox
TM
 
Green for cellular nuclei 
detection, imaged by CM, using a 
63x objective in 88% glycerol 
and 488 and 632 channels, 
respectively for AlexaFluo 647 
and Sytox
TM
 Green detection. A) 
Green channel detecting Sytox
TM
 
Green (epithelial cell nuclei). B) 
Red channel detecting AlexaFluo 
647 (glomeruli). C) Image in 
overlay. Scale bars: 100µm 
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In order to evaluate the physical modifications and glomerular size changing after perfusion, 
clearing and ECi removal/rehydration, some experiments were performed. First, after each 
step some pictures were taken, as reported in Figure 4.46; second different measurements 
were performed on glomeruli diameter by using the Las X software and taking the largest 
point in a z-scan, as reference (Fig. 4.47). 
 
 
 
 
 
 
 
 
B C A 
Figure 4.46: Mouse kidney slices (1mm) after perfusion (A), ECi-based OTC 
(B), ECi removal and rehydration (C). This picture shows the appearance of the 
mouse kidney slices after each step prior to the antibody staining itself. Sqare 
paper unit of measurement: 1mm. Images acquired by Samsung SM-J53F 
 
C 
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As shown from the graph, an increase of the glomerular size was noticed: 1) between group c) 
and a): +18.50µm; 2) between group c) and b): +13.12µm; 3) between group b) and a) 
+5.38µm. 
 
Figure 4.47: Glomerular size changing based on diameter measurement (Las X 
software). Bar plot show the measurement immediately after the perfusion (on the left-
group a), after the clearing procedure (center- group b) and after the rehydration step 
(on the right- group c). An oneway ANOVA test was performed to compare the mean 
values for the three groups. The asterisk denotes significance (p < 0.05) in paired t tests 
and error bars denote SD. The sample size is n=6. RH= Rehydration. 
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5. Discussion 
Starting from the original ECi-based OTC protocol
52
, a new optimized procedure was 
developed. This optimization consisted in: a) strongly shortening the times, by optimizing the 
protocol steps. In fact, the timing of the protocol was reduced from 16 hours (as described in 
the published protocol
52
) down to 5 hours (although the samples may stay longer in the ECi 
solution, for example overnight); b) completely automating the procedure with the use of the 
tissue processor, where all the settings may be easily programmed and it is possible to clear 
many samples in one run, without affecting the efficacy of the clearing. Moreover, the tissue 
processor assures the presence of a negative pressure, which prevents the formation of air 
bubbles in the samples; c) making the dehydration step faster and shorter. By skipping the 
step with 30% and 70% ethanol (as described by Klingebrg
52
), in this optimization, the 
samples were brought from 50% directly to 80% ethanol, ensuring a stronger and faster 
dehydration, before immersing the samples into absolute ethanol; d) changing the temperature 
from 4°C to RT, in order to improve the diffusion coefficient of the substances, so that they 
may better penetrate and diffuse into or out of the tissues. Two of the mainstays of this 
protocol are the speed of action and the low harmfulness of the ECi, being also a FDA-
approved food flavor and additive for cosmetic products since 2007
54
. Furthermore, different 
toxicity studies were conducted on ECi (oral, dermal, intramuscular studies, both on animals 
and humans), demonstrating that the use of ECi is not toxic and it can be used in different 
preparations of daily life (e.g. body lotions, face creams, bath products)
64
. 
By contrast, many other OTC protocols, which have been described during the last years, are 
highly time-consuming, being based on very long incubation times (days to weeks). 
Moreover, they also require very expensive, harmful and hard to handle clearing solution, as, 
for instance, in ACT (active clearing technique), X-Clarity, Scale, BABB, CUBIC
23-25, 65, 66
. 
In addition, substances with high RI values are considered better to obtain an optimal tissue 
clearing, as they can easier match with the RI of the biomolecules, where the RI overall tissue 
is generally defined in a range of 1.4-1.5
4, 9, 10
. However, one of the most important drawbacks 
of these high RI clearing solutions is their toxicity and harmfulness
1
. The high ECi RI, 
together with its no-toxicity, makes that an optimal clearing solution, given its ability to 
homogenize the tissue RI, with a strongly reduced risk for the operator. In addition, the use of 
ethanol is strongly recommended to remove membrane-associated lipids
67
. In fact, due to their 
chemical properties (presence of hydrogen bindings, electrostatic and hydrophobic 
interactions), the ethanol is the best candidate for the removal of lipids from cell bilayers 
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membranes
67
. Therefore, the speed of action ensured by the automation, high RI combined to 
the low harmfulness and economy of the product, make our ECi-based optimized OTC one of 
the best choice in this scenario. 
5.1. Advantages of a retrograde perfusion 
In the blood circulation, different molecules (as haemoglobin and myoglobin) contribute to a 
strong light absorption and, consequently, to the autofluorescence phenomenon, which may 
interfere with further analyses of the samples
2
. In order to reduce this inconvenience, the 
perfusion technique aims to remove blood from the body of the animal, under anesthesia. 
Depending on the purpose, two main approaches of perfusion have been described, retrograde 
and antegrade perfusion. In particular, the first one was described by Langendorff in 1895
68
. 
He established a retrograde way to perfuse animals, so that the perfusion buffer may flow 
retrogradely up the aorta, in an opposite way than the normal physiologic flow
68
. With that it 
is possible to perfuse by using either constant pressure or constant flow
68, 69
, and a cheap 
equipment. In Langendorff’s original work, the constant pressure was achieved by using a 
pressurized chamber connected to a manometer
68, 69
. Other reasons for the longevity of the 
retrograde perfusion are the simplicity of the preparation and the reproducibility of the 
method. The constant pressure/flow assures the integrity of the organs, after their harvesting 
from the animal body
69
. 
On the other hand, in the antegrade perfusion the perfusate is injected from the apex of the left 
ventricles
70
. 
Regarding the efficiency of either retrograde or antegrade perfusion, although there are 
conflicting opinions, the best choice depends on the experimental set-up
69-71
. 
Our group established a retrograde perfusion protocol, which is suitable for the use with OTC 
and microscopic analysis
53
. It allows the circulation of the dye in all the organs of the body so 
that it becomes possible to stain and harvest all organs in one run. One of the most important 
advantages of this method is the strong reduction of the number of animals used in the 
experiments, as it becomes possible to use all organs in one single go and to comply with the 
3Rs animal research principle (Replacement, Reduction and Refinement)
72
. 
Moreover, the pressure and the perfusate volume, kept constant by the use of a compressor 
and a syringe pump, assure the optimal quality of the samples. For a mouse, the amount of 
dye, injected per minute, was set to be 1ml; this is quite in accordance with Langendorff’s 
procedure, who, initially, had set the amount of the perfusate, for a mouse, at 2ml/min
68
. 
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Also, the retrograde way of perfusing is applicable to different strains of animals, such as 
mouse, rat, rabbit
69
. Lastly, the efficiency of our protocol is given also by the economy of the 
equipment, as well as the rapidity by which it is performed. In fact, for a mouse, without 
considering the dye injection, the whole procedure would take only 12 minutes (6 min. for 
saline and 6 min. for 4%PFA). 
5.2. Main differences between the original and optimized ECi-based OTC  
This paragraph illustrates the main differences between the two ECi/based protocols. 
Firstly, the shrinkage rate: as indicated in Figures 4.32, 4.33, 4.34, the shorter dehydration of 
the optimised protocol, although stronger, reduces, with some exceptions, the shrinkage rate 
in terms of weight, area and volume of the tissues.  
An eventual event of shrinkage/swelling, after a general OTC procedure, could affect the 
integrity of the inner structures and, consequently, the quality of the imaging. This is the 
reason why a good OTC protocol should not provoke a pronounced shrinkage or expansion. 
Although avoiding completely this phenomenon is not possible, it is however crucial to 
minimize it. The different organs present unique properties of swelling/shrinking
73
.  
The shrinkage studies conducted indicate that in terms of weight, the organs under discussion 
lost more weight after the ECi-based OTC described by Klingberg
52
 as well as in our 
optimised protocol. The different concentrations and timing for each ethanol step, in the two 
different protocols, play an important role. The incubation time for each passage in ethanol, 
described by Klingberg and coworkers, lasts 4 hours at 4°C 
52
. Indeed, in our optimised 
protocol, each ethanol step lasts only 45 minutes. Moreover, skipping one step reduces the 
risk of a pronounced shrinkage. The only exception regards the lung, which seems to gain 
weight after both procedures and that could be explained by its soft and sponge-like structure, 
which could enhance the gain of weight by absorbing solutions
73
, causing a swelling 
phenomenon. This is also confirmed from the surface area evaluation: if after our protocol, 
the lung seems to loose almost 60% in surface, after the original one, the gain in surface is 
roughly of 50%. Once again, due to its structure, the ethanol timing could have provoked a 
bigger absorption and, consequently, an increase of the surface.  
A different trend has been described for the changes in volume in heart, kidney and liver. The 
optimized protocol seems to have provoked less shrinkage compared to the original protocol, 
although for lung and spleen the situation seems to be the opposite. In addition, the 
comparison performed on the amount of lipids extracted, before and after both the ECi-based 
OTC protocols, revealed no significant differences: both the procedures remove lipids with 
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the same efficacy. As already mentioned, lipids from cell membranes are one of the most 
prominent causes of light scattering, which should be removed in order to reach a good 
quality in OTC. Moreover, membrane-associated lipids are characterized by hydrogen bonds, 
electrostatic and hydrophobic interactions, which allow them to be linked to membrane-
associated proteins
67
. Due to this chemical architecture, the most suitable way of extraction is 
the use of polar solvents, as ethanol or methanol, in order to disrupt these types of chemical 
bonds
67
. Another important parameter to take into account is the temperature by which the 
lipid extraction occurs. To achieve an optimal rate of extracted lipids, the temperature should 
be kept at RT or even lower, whenever required
67
.  
In terms of quality of imaging, we can state that the optimized procedure improved and 
ameliorated the previous one, making it available even for other different aims. 
5.3. Stability of the dye 
As demonstrated by Figures 4.35, 4.36, 4.37, long time storage (years) of the samples in ECi 
affects only partially the fluorescence of the dyes. This is in contrast, for instance, to the 
3DISCO, where one of the drawbacks is given by a fast degradation of the fluorescent signal 
due to the clearing solution. Because of that, the sample should be imaged as soon as possible 
after the clearing 
21. Our findings are in accordance with Klingberg’s protocol52. Considering 
also the use of different dyes (nanoparticles, WGA Alexa Fluo 488 conjugated, H&E), the 
evidence is that a) many and different dyes may be perfused accordingly to our protocol 
which guarantees their survival; b) a long storage in ECi affects only partially the 
fluorescence of the dyes perfused, allowing a second imaging even after two years. This could 
give the opportunity to create archives of cleared tissues, suitable for long-term studies, 
without sacrificing a big number of animals (even when not necessarily needed), in 
accordance with the 3Rs animal research principle
72
. 
5.4. Imaging 
In the imaging context, all the parameters were tailored, in order to acquire the best 3D image 
possible. First of all, samples RI correction: in order to achieve the optimal RI matching 
between the samples and the mounting media, the cleared specimens were stored in the 
chosen mounting medium for 24-48 hours before the imaging (except for the ECi), in the 
same microscope environment at RT. This was important, as the RIs of the most used 
mounting media were evaluated at temperatures near to RT: immersion oil (R.I.1.518 at 
Discussion   - 111 - 
 
23°C), 88% glycerol (R.I.1.475 at 20°C
55
) and ECi (R.I. 1.558 at 25°C
57
). These 2 precautions 
contributed to an optimal matching of the diverse RIs. 
Another important aspect was the choice of the dyes and/or fluorochromes. Although very 
different in their mode of operation, the two microscopes (CM or LSM) have some 
parameters in common, to be taken in consideration. In fact, in case of a double or multiple 
staining, it is important to choose dyes with well-separated excitation and emission spectra, to 
avoid overlapping and, thus, cross-talk
74
. For this reason, in our experiments, when a multiple 
staining was required, dyes with distinct spectra were used, such as Cy-7-PEI in combination 
with WGA-AlexaFluo 488 conjugated or for the 3D-IHC, AlexaFluo 647 in combination with 
Sytox Green. To avoid the overlapping and cross-talk phenomena a NIR and green region 
dyes were used. Additionally, to further bypass that, in case of double staining, a sequential 
scanning was used
75
. 
As already explained, immersion oil was used as mounting solution, for confocal analysis. 
This helped in:  
a) Circumventing the risk of ECi evaporation, caused by the long timing if imaging on CM. 
Due to that, as substitute of ECi, a mounting solution with a similar value of RI was required. 
In fact, the RIs mismatch between the clearing and mounting solutions results in a very strong 
reduction of axial resolution, where one of the worst consequences is the distortion of the z-
axis and, therefore, loss of structural data
75-77
. In addition, the achievement of the best 
resolution (in terms of optical aberrations and out-of-focus, which may negatively affect the 
signal-to-noise ratio) is only possible by working in a very homogeneous RI environment
78
;  
b) enhancing both the optical transparency and, consequently, the axial resolution, as recently 
demonstrated by Fouquet and co-workers
76
. According to them, the use of high RIs (≥1.5) is 
considered much better for achieving a very good quality of tissue transparency and for the 
improvement of the axial resolution in the imaging
76
. 
On the other hand, for LSM analysis, a change in the mounting solution was not necessary. 
The speed of imaging of this microscope allowed us to use ECi, even as mounting solution, 
without facing the danger of a quick evaporation and a RI mismatch. 
In order to prevent the z-axis distortion also the way of placing the sample on a specific 
support should be considered. To image the samples by CM, a 60mm Petri dish was chosen. 
This was completely filled with immersion oil and the organ anchored in the center of the 
dish, by a needle and adhesive paste. In this way, the sample was held securely, unable to 
move, allowing the perfect imaging of all the axes, especially of the z-axis, without losing 
structural data and information.  
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For this purpose and considering also the hardware of the Light Sheet (for example the space 
between the mirrors and their orientation as well as the working distance of the objective), the 
placing of the sample was an essential step to prevent the out-of-focus and the consequences 
of this. So, any sample was placed in a glass bottom Petri dish. Thanks to this glass bottom, it 
was possible to avoid the eventual corrosion of the standard plastic dish caused by ECi. In 
addition, to prevent the breaking of the dish, the specimen was used to be pasted on a little 
piece of parafilm. This helped in raising the organ up, without affecting the matching of the 
RIs. All of these experimental conditions assured a successful imaging. 
Lastly, for both microscopes, the acquisition settings were established in a way to reduce the 
time of acquisition, without influencing the quality of the final result. However, the 
acquisition time depends also on several other criteria, such as the number of tiles (marked by 
the stage overview option, tool of Las-X software), the depth (z-size) assigned as well as the 
type of objective used. For instance, the acquisition time, from CM, for a sample of 25 tiles 
and 446.53µm of z-size, imaged by a 20x objective, lasted 90 minutes. Due to all of these 
criteria, the acquisition time represents a very variable parameter. In addition to that, in every 
single experiment, the laser intensity, pinhole and the choice of the depth to be imaged had to 
be adjusted in order to prevent pixel oversaturation or low signal, which could have otherwise 
diminished the quality of the pictures
74
. 
Moreover, the LSM settings required also to optimize the binning value, defined as a process 
by which the signals from close pixels are combined into one value
74
. A small binning value 
results in a phenomenon known as “oversampling”, which may prolong the acquisition time 
and increase the risk of photobleaching of the specimen
74
. Another problem is in the amount 
of generated data, which strongly increases when a small binning value is used. In fact, for a 
high resolution (no binning) tile scan, made by both mirrors, the range of generated data was 
between ~300 and ~600 GB. Indeed, by reducing the resolution to 2*2 binning, the data 
amount for a both mirrors tile scan was estimated to be in medium range of 100 GB (in some 
cases, even less). These data refer to tile scan of mouse pole kidney and mouse spleen. 
Similarly to what happens for the confocal imaging, the acquisition time is dependent on 
these working conditions. For instance, the imaging of the pole of a mouse kidney 
(corresponding to 1/3 of the whole organ), with the highest resolution, two different channels 
and both mirrors, total depth 1.5mm, lasted 2 hours and 20 minutes, plus some additional time 
for the merging step. On the other hand, the imaging of the same sample, at the same 
conditions as before, with a lower resolution (2*2 binning), lasted 1 hour less, plus some 
additional time for the merging step. Considering that, a 2*2 binning value, in combination 
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with a 600Hz of speed of imaging, was established as optimal value to guarantee a good 
imaging in a reasonable time and amount of generated data. 
5.5. Analysis of pathological samples 
In order to extend our protocol on the diagnostic field, some pathological rat kidneys were 
cleared and imaged. The two pathologies investigated were cisplastin and genetic PCK 
nephrotoxicity.  
Cisplatin is a chemotherapeutic drug used in the treatment of a wide variety of neoplasias
49, 79
. 
The nephrotoxicity induced by cisplatin has been recognized and evaluated since its 
introduction
80
. The consequences of cisplatin-induced AKI and CKI were discovered both on 
molecular and histological levels
49, 79, 80
. The 2D and 3D images acquired from these 
specimens confirm the presence of cisplatin-induced AKI, especially in terms of as tubular 
dilatation and inflammatory infiltrate, clear signs of injury. Moreover, considering the 
injection time (the perfusion occurred 14 days after the first cisplatin injection), these findings 
are also in accordance with data of other authors, who stated to have found all of these 
symptoms after the fourth day of the injection, more and more increasing until six months 
later
49
.  
Also the imaging of PCK rat kidney confirmed what was described by Wilson and co-
workers
50, 51
.  
Therefore, it is possible to ascertain that our protocol is able to distinguish among physiologic 
and pathologic animal samples. Hence, this could become a useful tool also for human 
diagnostic field. 
5.6. “Re-vitalization” of histology samples from paraffin blocks 
We found that it is possible to re-vitalize even samples from 20 years old paraffin blocks, 
giving the opportunity to re-use the old paraffin blocks as archives of structural information. 
Recent publications have highlighted that liquid paraffin might play a very important role in 
OTC
81, 82
. Considering also its RI, which is equal to 1.4691+0.0003 at 20°C
81
, it has been 
possible to create a mixture 1:1 of liquid paraffin and glycerol (RI: 1.475+0.0003 at 20°C), 
which worked as optical reagent, in order to clear both fresh and de-paraffinised tissues
81, 82
. 
Furthermore it has been clarified how mixtures between lipophilic and hydrophilic substances 
could improve the OTC, in a synergic way, as liquid paraffin enhances the glycerol 
penetration into the tissues
82
 and, in the meantime, glycerol acts as optical clearing reagent. In 
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addition, glycerol can reduce the discontinuity in the RIs, improving the quality of the OTC 
and, blocking the evaporation of water, which prevents the tissue shrinkage
81
  
In our group, a method to “re-vitalize” and clear the old paraffin blocks, including de-
paraffinization in xylene, dehydration and clearing in ECi, has been established. In addition, 
this method has been also automated, by using the Leica EMTP, which can easily be 
programmed. With that, it is possible to de-paraffinize and clear in one run old samples and 
use the autofluorescence as an alternative staining, in order to visualize inner structures. 
Kidney, lung, heart from ADPCK rats were treated and microscopically analyzed, obtaining 
promising results: in fact, blood vessels with erythrocytes inside were clearly visible. Even 
paraffin embedded human renal biopsies were treated in this way: the complexity of the 
human morphology might cause a wider light-scattering
81
. However, the re-vitalization of old 
paraffin blocks might provide a solution in order to clarify those dubious pathologic situations 
and make more accurate diagnosis, which could not be done by using only standard histology 
and slides of a few µm
82
. Additionally, paraffin-embedded archives could also be used in 
order to intensify the field of research. This is especially true if data integration centers are 
build up (BMBF funding) and deep learning techniques are used. 
Another big advantage of this technique is the use of label-free samples: the use of 
autofluorescence as alternative staining could give the opportunity to visualize 3D tissue 
architecture and to easily differentiate between healthy and pathological situations
82
 . 
Moreover, it would be also possible to use the autofluorescence from erythrocytes to track 
and follow the blood vessels.  
5.7. ECi-OTC and 3D immunohistochemistry (3D-IHC)  
Another important step onwards has been the establishment of a 3D-IHC protocol, after the 
removal of ECi during a rehydration step. 
Compared to the previous procedure, where the antibody was injected intravenously in mice, 
during their sacrifice
52
, in our lab a method to remove the ECi from samples using a 
rehydration step was developed, allowing the staining of renal glomeruli as well as epithelial 
cell nuclei. There are many advantages in using this procedure:  
1) In the original protocol, more generic antibodies were used, such as CD11 and CD3152, in 
order to allow them to be spread in the whole mouse body before the perfusion. With our 
method it is possible to fine stain single structures, as the renal glomeruli, with a more 
specific antibody, as, in our case, the one against nephrin. 
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The large amount of solutions and the duration required for the whole procedure was 
identified as drawbacks for this staining: in reality, these two aspects assure both the 
specificity of the staining and a low level of background and noise. 
Furthermore, all the steps of our procedure are easy to handle, without using harmful 
substances; 
2) Despite some changing in the color, after the ECi removal and the following rehydration 
(as reported in Fig. 4.46), this process does not reduce the efficacy of the tissue clearing. 
In fact, the color of the samples, after the rehydration remains the one that the samples 
have immediately after the perfusion, which is due to the re-gain of water. The crucial 
point is the loss of the lipids after the clearing process: despite the re-gain of water, the 
optical transparency of the tissues does not change. Moreover, the rehydration step 
enhances the efficiency of the 3D-IHC, which could not be performed in the lipophilic 
ECi environment; 
3) In the imaging context, coming back to the aqueous RIs provides the opportunity to use a 
more versatile mounting solution, such as glycerol. In fact, given its more compatibility 
with different objectives, it is possible to facilitate the imaging procedure, without using 
an objective with a specific RI, as it is needed for ECi. 
Additionally, the preliminary incubation into glycerol, prior to the imaging, does not only 
permit a better RIs matching, but also a better diffusion of the mounting solution, which is 
reflected in clearer and sharper final results; 
4) The reversibility of ECi-based clearing process has also been proven, by following this 
new protocol. That means it is possible to optically clear samples with ECi and keep the 
efficacy of the clearing, although it is removed and “substituted” with other solutions. 
 
As reported in Figure 4.47, after the rehydration step, a little expansion of the tissue was 
noticed. However, the structures of interest appeared not affected by the ECi removal with the 
rehydration step. Also, this increase, combined with the use of the 63x objective helped in 
defining microstructures such as, for instance, the foot processes in the glomeruli. As 
conclusion, it is possible to state that: 1) the rehydration phase does not provoke a wide 
enlargement of the structures, so that it is possible to stain them without facing this issue; 2) 
this protocol could also be used for all the specimens that cannot be perfused, as, for instance, 
human samples from biopsies. 
In addition, with this new protocol, we also proved the reversibility of the ECi-based OTC. 
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6. Summary 
OTC defines a large group of techniques, aiming to make the tissues optically transparent, in 
order to be microscopically analysed. This is considered an important tool in the progress of 
the biology, as with that it is possible to reconstruct in 3D physiologic and pathological 
processes at different levels, from whole animals, organs down to a subcellular level. 
The optical transparency is an important pre-requisite to achieve the 3D reconstruction. Every 
living specimen is characterized by a set of highly light-absorbing molecules, where the most 
important are considered the blood molecules (haemoglobin, myoglobin), which provoke the 
autofluorescence phenomenon that may negatively interfere with the microscopic analysis. 
Another important class of biomolecules considered to be a negative factor for the OTCs are 
the bilayer membrane associated lipids. In fact, these molecules, together with other 
components, contribute to create the milky and opaque appearance, which does not allow an 
effective 3D imaging. In addition, due to their chemical structure, these molecules enhance 
the event of light scattering. In order to reduce as much as possible this combination of factors 
and to reach the optical transparency and, thus, make the 3D imaging possible, the main 
principle of OTCs is to remove lipids from the sample. However, in order to reduce also the 
autofluorescence phenomenon, a preliminary action is often required, that is the perfusion 
aiming to remove blood (and, therefore, blood molecules) from the body of the animal. 
Additionally, one of the most important parameter to take into account is the RI of the 
different solutions, as it also defines the quality of the 3D imaging. In fact, as the OTCs are 
based on the use of clearing solutions and the 3D imaging on mounting solutions where the 
different objectives are immersed in, the perfect matching of both RIs is of primary 
importance, to obtain images with high resolution. Actually, clearing solutions with high RIs 
are considered optimal, as these can match better with the RIs of biomolecules. 
Our OTC approach is divided into three steps: a pre-processing, that is the perfusion (removal 
of blood and staining of all organs), the OTC processing and the post-processing, as the 
microscopic analysis.  
Our work aimed at the optimization of all the three steps. In fact, we worked in order to: 1) 
speed up the perfusion procedure. Moreover, our perfusion approach works in a way that is 
possible to stain all the body of the animal in one run, so that the collection and harvesting of 
all organs becomes easier. This also helps in reducing the number of animals used for in vivo 
experiments; 2) optimize a pre-existent ECi-based OTC
52
. ECi is a lypophylic solution, with 
high RI, that can better match with the RI of biomolecules. Our optimization consisted in 
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accelerating all the procedures and automating them, using a tissue processor, which allows 
the run of multiple samples in one go; 3) optimize the settings of the imaging in terms of 
samples mounting, image acquisition time and amount of generated data.  
By optimizing all three steps, it was possible to establish an entirely new process also suitable 
for different and many samples (from mouse, rat, until human samples).  
Although many dyes were tested, the most used staining was the Cy7-PEI, a dye previously 
synthetized at the ZMF department of the Universitäts Klinikum of Mannheim, Germany. 
This was injected during the perfusion, in order to fluorescently stain and to microscopically 
detect fine structures, such as renal glomeruli and blood vessels.  
The optimized clearing procedure was amply tested, before going on and implementing that, 
in order to make that available also for other studies, such as the “re-vitalization” and further 
analysis of old histology samples from paraffin blocks as well as for 3D-IHC. Especially this 
latter implementation proved that the ECi-based OTC is a reversible process, as the 3D-IHC 
was preceeded by a removal of the ECi by a rehydration step and we demonstrated that this 
did not affect the quality of the clearing and, also, further staining and analysis were possible.  
Compared to other OTCs, our ECi optimization was safer, as ECi is a no-toxic reagent, faster, 
since the whole procedure takes 4 hours (although the samples may stay longer in the 
solution) and cheaper, especially concerning the price of the ECi for 1 liter.  
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